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PHYSICS OF MR IMAGE DISTORTION: IMPACT ON BREAST CANCER
RADIOTHERAPY
Amy L. Walker
A Thesis for Doctorate of Philosphy
Centre for Medical Radiation Physics
University of Wollongong
ABSTRACT
Magnetic Resonance Imaging (MRI) has superior soft tissue contrast compared to Com-
puted Tomography (CT). This soft tissue contrast can be utilised to enable improvements in
delineation of tumour and organ at risk volumes for radiotherapy treatment planning. CT
is the imaging modality currently utilised for radiotherapy treatment planning. It provides
accurate geometry of patient anatomy and provides electron density information as required
for dose calculations. Currently, MR images are generally fused with CT images to enable
the generation of radiotherapy treatment plans. There are continual advances being made to
enable use of MR images alone for radiotherapy treatment plan dose calculations, as well as
for in-room image guidance.
Geometric distortions associated with MRI are still a limiting factor in its more widespread
application for radiotherapy treatment planning, where accuracy is a crucial requirement.
Systematic distortions result from inhomogeneities in the magnetic field of the scanner, and
nonlinearities in the gradient fields which combine to localise the signal from within the
scanner. The patient introduces additional geometric distortions from differing tissue sus-
ceptibilities also leading to geometric uncertainties. The aim of this thesis was to quantify
the distortions across a large field of view as would be required for radiotherapy treatment
planning and determine implications of these geometric distortions on whole breast radio-
therapy.
The initial work conducted in this study looked at quantifying systematic geometric distor-
tions associated with MRI to determine the magnitude of geometric uncertainty when util-
ising MRI in the treatment planning process. This is of particular importance if considering
the use of MR images alone for treatment planning purposes. A 2-dimensional diagnostic
phantom was initially scanned on four diagnostic scanners with a number of standard clin-
ical imaging sequences. Distortion vector maps were found to differ between scanners due
to the individual performance specifications for each system. Differences in distortion mag-
nitude were observed for different acquisition sequences. A comparison was made between
images acquired with and without the application of a vendor supplied correction algorithm
for one of the scanners. The maximum distortion observed was reduced from 5.0 mm to
2.3 mm for a spoiled gradient echo sequence when the distortion correction algorithm was
applied. The distortion maps were compared to the positions of various anatomical sites
within the bore of MRI scanners. Distortions are larger in magnitude in regions where the
lung and breast volumes can be located.
The phantom utilised in the first section of this study did not enable the determination of
distortions across a large field of view (FOV) as required for the purposes of radiotherapy
treatment planning. Hence, a phantom was developed to meet this need. This phantom
was then scanned on a MRI scanner dedicated for imaging for radiotherapy, to quantify
the residual distortions observed on the system. Two approaches for reducing geometric
distortions were examined, namely the application of a vendor-supplied 3D correction al-
gorithm and image acquisition with a continuously moving table. The maximum distortion
was halved when the vendor supplied 3D correction algorithm was applied as opposed to
only the 2D correction algorithm. For a standard spin echo sequence, the maximum dis-
tortion was reduced from 9.81 mm to 4.37 mm. Differences in distortion distribution were
observed between images acquired with a conventional static couch to those acquired with
a continuously moving table (TimCT). TimCT enabled the whole phantom (length of 513
mm) to be imaged, whereas the conventional static table acquisition only imaged 71% of
the volume. Additionally, the magnitude of the distortions observed was also reduced from
6.1 mm (71% phantom volume) to 4.4 mm with a table speed of 1 mm/s (100% phantom
volume). While the distortions are reduced with the moving table acquisition, blurring is
introduced into the image due to the movement of the table and the amount of distortion
increases with increasing table speed (maximum distortion 5.8 mm at a table speed of 2
mm/s).
The final section of this thesis investigates the implications of geometric distortions from
both system and patient sources, on whole breast radiotherapy treatment planning. A ret-
rospective study was performed on data from 18 patients that underwent whole breast ra-
diotherapy as part of their treatment. To simulate the effects of MRI systematic geometric
distortions, deformation maps obtained from phantom measurements on two different scan-
ners were used to deform the original patient CT images. To assess the impact of combined
patient and systematic geometric distortions, CTs of the patient were deformably registered
to the corresponding patient MRI. Whole breast IMRT treatment plans were generated on
these altered CT datasets then the radiation dose recomputed on the original image, in order
to determine the impact of these distortions on the treatment planning process. The effects
of the systematic distortions alone had a minimal dosimetric impact. The combined effects
of the patient and system induced geometric distortions resulted in distortions within the
lung of 11.3 ± 8.6 mm compared to 3.0 ± 1.3 mm with only the systematic distortions
present. A dosimetric impact was observed for 8 of the 18 patients, with a mean variation
in PTV V47.5Gy coverage of 0.2± 2.2% across all patients, indicating that the geometric dis-
tortions resulting from the patient within the magnetic field is the largest contributing factor
for whole breast radiotherapy.
When considering incorporating MRI into the radiotherapy treatment planning workflow,
geometric distortions must be considered. Geometric distortions should be quantified on
any scanner to be utilised for radiotherapy so that the limitations of the system are known
and the potential impact assessed.
KEYWORDS: Magnetic Resonance Imaging, Geometric Distortion, Phantom, Breast
Radiotherapy
Acknowledgements
Firstly, I would like to saw a huge thank you to my supervisors for getting me through
the past three and a half years. To Peter Metcalfe, thank you for the continued support
over the past few years, for always being around (on my good and bad days) when I needed
direction, focus and someone to keep me on track to get this "stuff" done. Thank you to Lois
Holloway. Her supervision, patience drive and motivation has been invaluable in keeping
my driven and motivated to progress my work and keep looking for now opportunities. To
Gary Liney, thank you for the MRI expertise brought to this project. This expertise and the
advice on my publications definitely helped my project along and kept things on track.
I would like to thank the staff at Liverpool and Macarthur Cancer Centres for their assistance
and support throughout the PhD. I would particularly like to thank Vikneswary Batumalai
and Shivani Kumar for having the patience to teach me treatment planning and always being
up for a chat, Robba Rai and Ewa Juresic for the MRI scanning and singing sessions, and
Michael Jameson for discussions about projects and future prospects. To Prof. Geoff De-
laney, Dr. Miriam Boxer, Dr. Mei Yap and Dr. Eng-Siew Koh, thank you for the numerous
plan checks conducted throughout this project.
Thank you to Jason Dowling and the guys at CSIRO for all of the support for the image
registration component of this project and allowing me to visit and get things all set up.
Thanks specifically to David Rivest-Henault for assistance with the deformable image reg-
istration, Neil Burdett for software support and Shekar Chandra for assistance with image
visualisation.
A lot of this work was very dependent on the acquisition and development of MRI phan-
toms. Thank you to Peter Greer for supplying the initial phantom which got the project
xiv
kick started, Jonathan Knott for helping to put together the design drawings for the de-
veloped phantom and Craig Davis for constructing the phantom. A huge thanks to Carrie
Glide-Hurst for providing phantom data and engaging in collaborative discussions. To Elise
Pogson, Kylie Dundas and Haijie Jin, thank you for the work conducted on the breast radio-
therapy planning scripts and showing my how to use the end product. It definitely helped
ensure that this project was completed in a timely fashion. A big thank you to the past and
present students and staff at the Centre for Medical Radiation Physics (CMRP) for making
the past several years quite enjoyable and for helping on another along the way. To Jayde,
Sally, Valentina, Pauline, Lauren, Brad, Weaver, Anthony, Anya, Jeremy, Stephen and Dean
(and others) thank you for the numerous coffee sessions and overall great times, something
I am sure I will miss as I move on from this chapter. Thank you too to the students from
around the world who have conduced some form of research through Liverpool Hospital
and the Ingham Institute. It has been a pleasure to meet you all and made the time spent at
the hospital enjoyable and interesting.
I wish to acknowledge the funding assistance supplied by the APA scholarship and the
Liverpool and Macarthur Therapy Centre Trust Funds. Thank you to the CMRP for the
opportunities received to travel nationally and internationally, allowing me to promote my
work and giving me opportunities to network and enhance my career prospects.
Finally, I would like to thank my family and Pete, for keeping me sane throughout these past
few years.
xv
Publication List
Published
A. Walker, G. Liney, L. Holloway, J. Dowling, D. Rivest-Hénult, P. Metcalfe, "Continuous
table acquisition MRI for radiotherapy treatment planning: distortion assessment with a new
extended 3D volumetric phantom", Medical Physics, 42, (4), 1982-1991 (2015)
A. Walker, G. Liney, P. Metcalfe, L. Holloway, "MRI distortion: considerations for MRI
based radiotherapy treatment planning", Australasian Physical and Engineering Sciences in
Medicine, 37, (1), 103-113 (2014)
P. Metcalfe, G. Liney, L. Holloway, A. Walker, M. Barton, G. P. Delaney, S. Vinod, W.
Tome, "The Potential for an Enhanced Role for MRI in Radiation-Therapy Treatment Plan-
ning", Technology in Cancer Research and Treatment, 12, (5), 429-446 (2013)
In Submission
A. Walker, P. Metcalfe, G. Liney, V. Batumalai, K. Dundas, C. Glide-Hurst, G.P. Delaney,
M. Boxer, M.L. Yap, J. Dowling, D. Rivest-Hénult, E. Pogson, L. Holloway, "MRI geomet-
ric distortion: Impact on tangential whole breast IMRT ", JACMP, (In Submission)
A. Xing, L. Holloway, S. Arumugam, A. Walker, G. Goozee, E. Juresic, R. Rai, L. Cassapi,
S.K. Vinod, G.P. Liney, "Commissioning and quality control of a dedicated wide bore 3T
MRI simulator for radiotherapy planning", International Journal of Cancer Therapy and
Oncology, (In Submission)
xvi
Conference Presentations
A. Walker, P. Metcalfe, G. Liney, V. Batumalai, K. Dundas, C. Glide-Hurst, G. Delaney,
M. Boxer, ML. Yap, J. Dowling, D. Rivest-Hénult, E. Pogson, L. Holloway, Impact of MRI
geometric distortion on tangential whole breast IMRT, Poster presentation, MR in RT Sym-
posium, Lund, Sweden, 2015
A. Walker, G. Liney, L. Holloway, J. Dowling, D. Rivest-Hénult, P. Metcalfe, Variations in
geometric distortion using static and moving table acquisition for radiotherapy treatment
planning applications, Oral presentation, World Congress on Medical Physics and Biomed-
ical Engineering, Toronto, Canada, 2015
A. Walker, G. Liney, L. Holloway, J. Dowling, D. Rivest-Hénult, P. Metcalfe, 3D mapping
of geometric distortion using static and moving table acquisitions for radiotherapy treatment
planning applications, Oral presentation, International Society for Magnetic Resonance in
Medicine 23rd Annual Meeting, Toronto, Canada, 2015
A. Walker, V. Batumalai, K. Dundas, G. Delaney, M. Boxer, ES. Koh, ML. Yap, P. Met-
calfe, G. Liney, J. Dowling, L. Holloway, Impact of MRI geometric distortion on tangential
IMRT breast plans, Oral presentation, MedPhys14, Sydney, Australia, 2014
A. Walker, V. Batumalai, K. Dundas, G. Delaney, M. Boxer, ES. Koh, ML. Yap, P. Met-
calfe, G. Liney, J. Dowling, L. Holloway, Impact of MRI geometric distortion on tangential
IMRT breast plans, Oral presentation, Combined Scientific Meeting, Melbourne, Australia,
2014
xvii
A. Walker, L. Holloway, P. Metcalfe, J. Dowling, G. Liney, An assessment of continuous
table acquisition for reducing MRI distortion in radiotherapy imaging using a new 3D vol-
umetric phantom, Electronic and static posters, Combined Scientific Meeting, Melbourne,
Australia, 2014
A. Walker, V. Batumalai, K. Dundas, G. Delaney, M. Boxer, ES. Koh, ML. Yap, E. Pogson,
T. Young, P. Metcalfe, L. Holloway, Comparison of planning techniques for supine whole
breast treatments, Electronic poster, Combined Scientific Meeting, Melbourne, Australia,
2014
A. Walker, L. Holloway, P. Metcalfe, G. Liney, Phantom development for full field of view
distortion assessment on an MRI simulator, Oral presentation, MR in RT Symposium, Saint
Louis Missouri, USA, 2014
A. Walker, L. Holloway, G. Liney, P. Metcalfe, A comparison of MRI distortion between
scanners and sequences for radiotherapy purposes, Oral presentation, AAPM, Indianapolis,
Indiana, USA, 2013
A. Walker, G. Liney, P. Metcalfe, L. Holloway, A comparison of MRI distortion between
scanners and sequences for radiotherapy purposes, Oral presentation, MedPhys13, Sydney,
Australia, 2013
A. Walker, G. Liney, L. Holloway, S. Deshpande, P. Metcalfe, An assessment of MRI dis-
tortion for the purpose of radiotherapy treatment planning, Electronic poster, 2nd ESTRO
Forum, Geneva, Switzerland, 2013
A. Walker, L. Holloway, G. Liney, P. Metcalfe, Phantom prototype development for MRI
distortion analysis for radiotherapy treatment planning application, Oral presentation, Med-
Phys12, Sydney, Australia, 2012
A. Walker, L. Holloway, P. Metcalfe, Prototype designs of a phantom to assess MRI distor-
tion for radiotherapy treatment planning, Oral presentation, EPSM, Gold Coast, Australia,
2012
xviii
Invited Talks
A. Walker, MRI distortion and the impact for breast RTP, Presented at the MRI linac col-
laborators meeting, Sydney, Australia, December 2014
P. Metcalfe, A. Walker, Distortion correction for MRI treatment planning and MRI Linac,
Presented at Micro-Mini & Nano Dosimetry and Prostate Cancer Treatment Workshop, Port
Douglas, Australia, October 2014
xix
List of Abbreviations
3D-CRT Three-Dimensional Conformal Radiotherapy
AAPM American Association of Physicists in Medicine
Ant Anterior
B0 Magnetic Field
BW Bandwidth
CISS Constructive Interface in Steady State
CSIRO Commonwealth Scientific and Industrial Research Organisation
CTV Clinical Target Volume
CT Computed Tomography
DSV Diameter of Spherical Volume
DVH Dose Volume Histogram
EBRT External Beam Radiotherapy
FOV Field Of View
Gd Gadolinium
GRE Gradient Echo
HU Hounsfield Units
IGRT Image Guided Radiotherapy
IMAT Intensity Modulated Arc Therapy
xx
List of Abbreviations xxi
IMRT Intensity Modulated Radiation Therapy
MRA Magnetic Resonance Angiography
MRI Magnetic Resonance Imaging
MU Monitor Units
MV Megavoltage
NMR Nuclear Magnetic Resonance
OAR Organs At Risk
PBI Partial Breast Irradiation
Post Posterior
ppm Parts Per Million
PTV Planning Target Volume
QA Quality Assurance
RF Radio Frequency
RTP Radiotherapy Treatment Planning
s-CT Substitute CT
SE Spin Echo
SMILI Simple Medical Imaging Library Interface
SMS Sliding Multislice
SNR Signal-to-Noise Ratio
ss-TSE Single Shot Turbo Spin Echo
TE Echo Time
TimCT Total Imaging Matrix, Continuous Table
TPS Treatment Planning Systems
List of Abbreviations xxii
TR Repetition Time
TSE Turbo Spin Echo
T Tesla
UTE Ultra-Short TE
V-interp Volume Interpolated
Chapter 1
Introduction
In radiotherapy, there have been continuous advancements in imaging and treatment tech-
niques. In order for new and emerging technologies to be utilised in a clinical scenario on a
daily basis, they need to show merit and benefit over the existing technologies.
The utilisation of Magnetic Resonance Imaging (MRI) in radiotherapy is increasing for the
purposes of treatment planning and image guidance [1]. MRI offers superior soft tissue in-
formation compared with Computed Tomography (CT), the current primary imaging modal-
ity in radiotherapy. This improved information can improve the accuracy in delineation of
tumour and organ structures, providing more targeted radiotherapy for patients [2].
One of the underlying issues with MRI that has previously restricted its widespread utili-
sation in radiotherapy is the geometric distortions inherent to the acquisition of images [3].
These result from both systematic sources, from the specific performance specifications of
the MRI scanner and patient induced factors resulting from differences in magnetic proper-
ties of varying tissues.
This thesis is an investigation of geometric MRI distortion and the potential consequences
for radiotherapy treatment planning. Methods for quantifying systematic distortions on a
dedicated MRI simulator are presented. This thesis also reports the implications of system-
atic and patient related distortions on whole breast radiotherapy treatment planning.
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1.1 Project Aims
This section outlines the scope of this project by stating the project aims with associated
research questions and the thesis chapters that address each research aim.
Aim 1. Compare the advantages and disadvantages of utilising MRI and CT for radiother-
apy treatment planning
Research questions:
What are the advantages of utilising MRI for radiotherapy treatment
planning?
What are the disadvantages and challenges of increased utilisation of
MRI for radiotherapy treatment planning?
Content Overview:
Chapter 2 summarises the literature on the use of MRI in radiotherapy treat-
ment planning (RTP). It addresses the benefits and limitations compared to
CT, the current primary imaging modality for radiotherapy treatment plan-
ning. Of particular focus is MR geometric distortions in the acquired images.
The causes and methods for dealing with them are investigated, as well as
potential implications for RTP.
Aim 2. Quantify MRI geometric distortion utilising a diagnostic imaging phantom
Research questions:
What are the variations in geometric distortion when scanning with and
without the application of a vendor supplied 2D correction algorithm?
What is the magnitude of geometric distortions corresponding to the
location of common radiotherapy anatomical sites within the scanner?
What are the limitations when using a 2 dimensional diagnostic imaging
phantom for measuring distortion for radiotherapy treatment planning
purposes?
Content Overview:
1.1. Project Aims 3
Chapter 3 details a phantom study investigating the benefits and limitations
of using a 2 dimensional diagnostic phantom to assess geometric distortion
for the purposes of RTP across four different MRI scanners. It addresses a
number of geometric considerations that must be made when utilising MRI
for RTP, including regions of the patient anatomy that are likely to experience
more substantial spatial mismapping and the effects of applying 2D correction
algorithms.
Aim 3. Design and construct a full field of view 3 dimensional phantom appropriate for
measuring MRI distortion for RTP
Research question:
What specifications are required for a full field of view phantom for MRI
distortion assessment for radiotherapy planning?
Is the designed phantom appropriate for measuring distortion for ra-
diotherapy treatment planning?
Content Overview:
Based on the limitations with the phantom utilised in Chapter 3, Chapter 4
details the development of a 3 dimensional, full field of view distortion phan-
tom.
Aim 4. Measure the geometric distortion on a 3 T scanner dedicated to RTP, comparing
conventional static image acquisition and acquisition with a continuously moving
table
Research questions:
What is geometric performance of the MRI scanner with conventional
acquisition sequences?
How do the distortion patterns obtained with a continuously moving
couch compare to static couch acquisitions?
Content Overview:
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Utilising the final phantom design from Chapter 4, Chapter 5 measures the
distortion on a 3.0 T closed wide bore MRI scanner. Distortion is quanti-
fied for conventional acquisition techniques and compared to the distortion
patterns observed when acquiring images with a continuously moving table.
These 2 techniques are compared to investigate if one acquisition technique
may be more useful in imaging various anatomical sites.
Aim 5. Assess the impact that MRI geometric distortion has on breast radiotherapy
Research questions:
Does MRI distortion impact the dose distribution for whole breast ra-
diotherapy treatment planning?
Can phantom measurements adequately predict the distortions for whole
breast radiotherapy?
Content Overview:
Chapter 6 investigates the impact of the MRI uncorrected distortions on whole
breast radiotherapy treatments with Intensity Modulated Radiation Therapy
(IMRT). The distortion impact is assessed by phantom measurements on a
high field closed bore system, phantom measurements on a low field open
bore system and patient specific factors on the high field scanner for tangential
whole breast radiotherapy treatments.
Chapter 2
Literature Review
2.1 Radiotherapy
Radiotherapy is a routine treatment technique for cancer. The aim of radiotherapy is to
utilise targeted ionising radiation to kill the cancerous cells, whilst sparing the surrounding
healthy tissues. External beam radiotherapy (EBRT) involves the treatment of tumours with
high energy photons produced by a linear accelerator. It was reported that as of 2012 that
ideally, 48.3% of new cancer cases in Australia would receive megavoltage (MV) EBRT at
some point during the course treatment [4].
2.2 Imaging for radiotherapy
Imaging of the patient anatomy plays an important role in the detection and treatment of can-
cer. Images are acquired during the patient diagnosis stages. If radiotherapy is prescribed,
the patient will undergo additional imaging for the purposes of planning the radiotherapy
treatment delivery. Figure 2.1 shows the basic radiotherapy workflow and the purpose of
imaging at each stage.
2.2.1 Radiotherapy treatment planning
In radiotherapy treatment planning (RTP), the patient is set-up and imaged in the position
required for their course of radiotherapy. These images are imported into the treatment
planning system (TPS) where radiation oncologists will define the tumour volume(s) to be
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Figure 2.1: Basic workflow of the radiotherapy process.
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targeted during treatment and organs at risk (OAR), which should receive the lowest dose
possible to avoid damaging normal tissues.
Treatment plans are created on these images and structures. The plans are generated to
meet the treatment requirements set by the radiation oncologist to meet individual patient
treatment needs.
Computed Tomography (CT) uses the attenuation of x-rays through the body to create 3D
anatomical images [5, 6]. CT is currently the primary imaging modality for RTP with all
EBRT patients undergoing CT-simulation prior to treatment. The electron density infor-
mation obtained from CT datasets is required for the treatment planning process for deter-
mining the dose distribution within the patient anatomy. CT numbers are integer values of
the attenuation of x-rays through matter. The electron density information relates to the
Compton interactions of high energy photons with matter [5]. Calibration curves are used
to convert CT numbers (Hounsfield Units) to electron density maps [7]. Dose calculations
such as convolution [8] and Monte Carlo [9] use raytracing [10] which relies on accurate
electron density maps in order to generate accurate dose maps. Since CT depends on varia-
tions in x-ray attenuation through the body, there is a limit as to how well certain anatomical
boundaries can be visualised, particularly between structures of similar attenuation.
In magnetic resonance imaging (MRI), the acquisition of images is based on the proton den-
sities and relaxation properties of tissues, as opposed to variations in x-ray attenuation (Sec-
tion 2.3). As such, MR images are superior in their ability to differentiate and characterise
soft tissue structures compared to CT [2] (Figure 2.2). Additionally, they do not use ionising
radiation to acquire the images. Due to these factors, the use of MRI for RTP has increased,
with potential benefits in defining tumour extent and stage [11–13], tumour localisation and
delineation [14–20], image guidance [21–27] and response monitoring [20, 28–31] during
treatment. Two limitations of MRI which have inhibited its more widespread use in radio-
therapy treatment planning are the geometric distortions inherent to the acquisition of these
images [32] (Section 2.4) and the lack of electron density information (Section 2.5).
2.3. Physics of MRI 8
Figure 2.2: Comparison of a breast imaged with CT and MRI. Visualisation of the seroma
volume is enhanced in the MR image.
2.3 Physics of MRI
MRI is based on the nuclear magnetic resonance (NMR) phenomenon - ‘study of the mag-
netic properties of the nucleus of the atom’ [33]. Since tissues within the body are primarily
composed of water, the hydrogen atoms within these molecules can be manipulated and
investigated.
Within a water molecule, each hydrogen nucleus spins around its own axis. In the presence
of an applied external magnetic field (B0), the nuclei begins to precess in a circular motion
in the direction of B0. The speed of precession is defined by the Lamour equation:
ω0 = B0γ (2.1)
where ω0 is the precessional frequency, B0 represents the strength of the applied magnetic
field in Tesla (T) and γ is the gyromagnetic ratio (42.57 MHz/T for hydrogen). The preces-
sional frequency of hydrogen is 63.86 MHz at 1.5 T and 127.71 MHz at 3 T, two common
strengths of current clinical MRI scanners.
When a radio frequency (RF) pulse is applied to the human body, perpendicular to B0 and at
the same precessional frequency as the hydrogen atoms at applied field strength, the hydro-
gen nuclei resonate in an excited state as they receive energy from the RF pulse. The nuclei
align in spin-up or spin-down states, creating a net magnetisation vector which produces the
MR signal. Once the RF pulse is switched off, the nuclei undergo free decay, relaxing to
their original, unexcited state. This process is governed by the relaxation times.
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There are two primary relaxation times critical to the acquisition of MR images (Figure
2.3). At time t after the removal of the applied RF pulse, the recovery of the longitudinal
magnetisation is defined as:
Mz(t) = M0(1− e−t/T 1) (2.2)
T1 relaxation (or longitudinal relaxation) is defined as the time required for the recovery of
the longitudinal magnetisation to 63% of its original value. It is often referred to as spin-
lattice relaxation due to its dependence on energy transfer between excited spin states and
the lattice structure of the tissue.
At time t after the removal of the applied RF pulse, the signal decay in the transverse plane
is defined as:
Mxy(t) = M0e−t/T 2 (2.3)
T2 relaxation (or transverse relaxation) is defined as the time required for the transverse
magnetisation to decay to 37% of its original value. It is also referred to as spin-spin re-
laxation time due to its dependence on the interactions of the magnetic properties between
adjacent nuclei.
T2* relaxation, like T2 relaxation, involves a decay in magnetisation in the transverse plane.
However T2* also incorporates magnetic field inhomogeneities and is much shorter due to
the dephasing of the magnetisation for individual nuclei.
Image contrast is governed by these relaxation times which vary depending on the relax-
ation times of particular tissues [2]. By exploiting the differences in relaxation times in
neighbouring tissues, T1, T2 or T2* weighted images can be created. Differences in repeti-
tion time between consecutive RF pulses (TR) and the times at which an echo is produced
after the RF pulse (TE) enable these differences to be exploited.
In 1973, Lauterbur proposed using magnetic gradients as a way of differentiating the loca-
tion of signal from within a magnetic field [34]. In modern MRI scanners, in order to dif-
ferentiate where signals are originating from within the scanner, a series of gradient fields
are superimposed over the main magnetic field in all three imaging planes. These gradients
provide slight linear variation in the total magnetic field across the whole imaging field of
view (FOV) so that no one point experiences the exact same magnetic field and the signal
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Figure 2.3: Comparison of the T1, T2 and T2* relaxation times.
information obtained can be spatially encoded. The three gradients are:
(i) Slice select gradient
(ii) Frequency encode gradient
(iii) Phase encode gradient
They are applied in a specific order, depending on the acquisition sequence in order to pro-
duce useful 3-dimensional anatomical images. The direction of these gradients will depend
upon whether the images are being acquired in the axial, sagittal or coronal planes. Figures
2.4 and 2.5 show the timing of these gradients with respect to the initial RF pulse and the
resulting signal for standard spin echo (SE) and gradient echo (GRE) sequences respectively.
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Figure 2.4: Schematic of a spin echo sequence showing the timing of the RF excitation
pulses and the application of the gradients.
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Figure 2.5: Schematic of a gradient echo sequence showing the timing of the RF excitation
pulses and the application of the gradients. θ represents the variable angle at which the RF
pulse is applied.
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2.4 MRI distortion
Due to the modality’s strong dependence on the main magnetic field and the gradient fields,
any imperfections in the performance of these results in distortions and artifacts in the im-
ages. Geometric distortions can arise from systematic issues from the scanner, as well as
from the presence of an object within the scanner [35].
2.4.1 Systematic distortions
System related distortions arise from variations of the scanner specifications. The two main
sources of systematic distortions arise from inhomogeneities in the B0 field and nonlin-
earities in the gradient coils. The B0 field in combination with the gradient field enable
localization of the signal from within the scanner. The homogeneity and linearity of the
field and coils deteriorate with increasing distance from the isocenter of the scanner.
1. B0 inhomogeneities
MRI scanners operate on the assumption that the B0 field is homogeneous. The ho-
mogeneity of the B0 field is measured in parts per million (ppm) over a Diameter
of Spherical Volume (DSV) extending out from the scanner isocenter. Homogeneity
values for current scanners are typically 1.1 ppm across a 50 cm DSV. For a 1.5 T
scanner, this corresponds to a frequency offset of 70.2 Hz. For an image acquired
with a pixel size of 1 mm x 1mm and an imaging BW of 220 Hz/pixel, this equates
to a geometric shift of 0.32 mm. Such variations in homogeneity creates discrepan-
cies in signal location and result in intensity variations and distortions within acquired
images.
Modern scanners allow for shimming of the B0 field, to improve uniformity in the
sensitive central volume of the scanner.
2. Gradient non-linearities
When acquiring images, MRI systems assume that the gradient coils have a linear
response. Since the performance of these coils is fundamental to the localisation of
signal (see Section 2.3), any nonlinearities create variations in signal location between
where it originates within the scanner to where the system perceives it to be (Figure
2.6). Hence, the result is a geometrically distorted image.
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Figure 2.6: Mismapping of voxels due to non-linear gradients. The apparent signal location
varies from the actual signal location within the patient.
General specifications for scanner body gradient coils on diagnostic systems is for the
gradient error to be less than 2% of the gradient strength over a 40 cm DSV [36].
Performance specifications of additional gradient coil inserts which may be utilised
in some situations are characteristically less than this, which can lead to increased
nonlinearity effects [37].
To reduce the distortions associated with gradient non-linearities, most vendors now
supply correction algorithms (in 2D and/or 3D) which can be applied on or off line.
While these algorithms provide a reduction in the geometric distortions present, they
are not completely eradicated [38, 39].
Improvements in technology with the shimming and correction algorithm options has seen
a reduction in the magnitude of geometric distortions. However the practicality of obtaining
a perfectly homogeneous B0 field and linear gradients remains challenging. Wider, shorter
bore designs in modern clinical MRI scanners to improve patient comfort [40] and increas-
ing the magnetic field strength to allow for faster imaging with improved imaging quality
makes the optimisation of scanners more challenging [3].
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Traditionally, scanners have been optimised to perform best within a spherical volume. Re-
cent design developments have seen a move towards cylindrically optimised magnets to
account for the changing scanner designs and to ensure the optimisation is more suited to
the imaging volume over the patient anatomy [41].
Each scanner has its own characteristic uniformity and linearity distortions.
2.4.2 Patient induced distortions
When placed within a MRI scanner, patients introduce additional imperfections in the ho-
mogeneity of the B0 field.
1. Chemical shift
Chemical shift arises from differences in the chemical structure of the nuclei of water
and fat molecules. Fat molecules consist of a carbon-hydrogen structure whilst water
has a oxygen-hydrogen molecular structure. This results in a variation of the resonant
frequencies of these two molecules, with fat precessing at a slower rate than water.
This chemical shift equates to a magnetic field variation of 3.5 ppm [3]. Chemical
shift results in tissues containing fat molecules to be shifted in the frequency encode
direction of the image.
2. Magnetic susceptibility
Magnetic susceptibility arises from variations in the magnetisation properties of dif-
ferent tissue types within the body. When a patient (or another irregular object) is
introduced into the scanner, the tissues become magnetised by varying degrees and a
field opposing the applied field is induced (i.e. a demagnetising field). The overall
field then varies throughout the patient volume (due to differences in tissue structures
throughout the anatomy) and can be determined by the sum of the applied and de-
magnetising fields. Susceptibility artefacts are largest at air-tissue interfaces where
the difference in magnetisation properties are greatest.
The variation in magnetic field creates geometric distortions and can produce signal
voids within the image. Distortion magnitude due to susceptibility in a cylindrical
bore with a parallel field can be defined by:
∆x = ∆χB0/GF (2.4)
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Where ∆x is the positional error, ∆χ is the difference in magnetic susceptibility, B0
is the main magnetic field strength and GF is the gradient strength in the frequency
encode direction [42]. Field perturbations can be larger than that observed with chem-
ical shift, with perturbations of between -5 to 6 ppm being reported for head and neck
[3] with the potential for variations as great as ± 9 ppm [42]. Susceptibility affects
are most prevalent in the frequency encoding direction of images.
Patient induced distortions are dependent on the field strength of the scanner. The difference
between the resonance of fat and water increases with field strength. Similarly, the positional
errors resulting from susceptibility variations between different tissues also increase with
field strength. Therefore the patient induced distortions are larger in magnitude at higher
field strengths than at a lower field strengths [35].
2.4.3 Managing MRI system distortions
The American Association of Physicists in Medicine (AAPM) report 100 for MRI quality
assurance (QA) [43] recommends the geometric accuracy of clinical MRI scanners be quan-
tified. A common method for characterising MRI geometric distortions is to obtain phantom
images with a known geometry and compare the apparent position of phantom structures
within the MR image to the known structure locations in order to create a distortion map
across the FOV.
While commercial phantoms have been available for distortion measurements, they have
previously been limited in size. This is useful when investigating the distortions across a
small FOV such as the brain [44, 45]. However when characterising distortion for a full
FOV which would be required for a more widespread implementation of MRI in RTP, these
phantoms do not cover the required area.
Many studies have developed their own phantoms in order to characterise larger FOV distor-
tions for radiotherapy. One of the earliest to do this was Bakker in 1992 where a rectangular
grid phantom consisting of tubes filled with sodium chloride or hydrogen sulphate was im-
aged on MRI [46]. Distortion magnitude was quantified by comparing the apparent grid
point locations from each tube with the known positions.
A number of studies utilise phantoms with liquid filled tubes surrounded by air to test for
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geometric distortions. The study conducted by Karger et al. investigated distortions within
the head, hence the phantom dimensions were limited to 23 cm length and 18 cm diameter.
Within this volume, they observed maximum distortions of 1.2 mm to 5.8 mm over 4 dif-
ferent scanners (mean: 1.0 mm to 4.6 mm) [47]. In a study by Tanner et al., a tube-based
linearity test object was utilised to quantify distortions over a larger FOV, with maximum
distortions of 16 mm observed in a volume corresponding to that required for whole pelvic
imaging [48].
Grid based phantoms designs are common for MRI distortion quantification. Crijns et al.
used a plastic box with a rectangular grid insert, surrounded with water [49]. The maximum
distortions observed were 2.9 mm, however this was only across the small phantom volume
of 150 mm x 150 mm x 30 mm. Grid phantoms designed to determine geometric distortions
for the purposes of RTP consist of multiple grid sheets layered in 3D within a box. The
box is then filled with a liquid solution, with the grid material producing no signal on MRI
resulting in visual control points from which the apparent point locations can be compared
to the known grid geometry. Wang et al. used such a phantom with external dimensions
of 310 mm x 310 mm x 310 mm [38, 50]. Within a 240 mm x 240 mm x 240 mm cube,
maximum distortion across four different scanners were found to range from 4.8 mm to
11.4 mm without vendor correction algorithms applied and 3.4 mm to 9.6 mm with vendor
corrections applied. Baldwin et al. investigated the distortions within a 300 mm x 300 mm x
300 mm phantom [40] and with the same phantom again but with additional lateral phantom
extensions to cover the entire magnet bore (578 mm) [51]. Over an imaging volume of 260
mm x 265 mm x 87 mm, peak-to-peak distortions were 5.4 mm, 5.0 mm and 1.6 mm (x, y
and z respectively). These values nearly doubled to 10.6 mm, 9.8 mm and 3.1 mm when
measured over a larger imaging volume (440 mm x 265 mm x 87 mm) .
Studies by Mizowaki et al. [52], Viard et al. [53] and Mah et al. [39] characterise the
geometric distortions observed on open-bore systems. Mizowaki at al. and Viard et al.
investigated scanners with a field strength of 0.2 T. Within the central FOV region (<100
mm), the maximum distortions observed were below 4 mm. Maximum distortions observed
were up to 15 mm within a 350 mm FOV (Mizowaki et al.) and 18 mm within a 190
mm radial distance from scanner isocentre (Viard et al.). These were largest at the outer
edges of the FOV and no vendor supplied correction algorithms were applied. The study
conducted by Mah et al. investigated the systematic distortions on a 0.23 T scanner with
post-processing distortion correction provided by the manufacturer. They observed reduced
2.4. MRI distortion 18
distortions compared to the previous two studies as a result of this correction, with maximum
distortions below 10 mm within a radial distance of 200 mm from scanner isocentre. Beyond
a radial distance of 200 mm, maximum distortions were observed to be > 40 mm without
correction which was reduced to 30 mm with correction.
In radiotherapy, the treatment planning process and treatment QA require a geometric ac-
curacy of within 2 mm [54]. Hence, comprehensive distortion mapping of each system is
recommended to determine the tolerances and constraints to minimise MRI distortion im-
pact for RTP or provide data for a correction scheme where appropriate.
A theoretical approach to correct for systematic distortions involves applying spherical har-
monic deconvolution methods [55]. This method is the basis for the correction algorithms
utilised on some commercial scanners and also includes a correction for intensity variations
induced by these distortions [47]. Distortions greater than 2 mm may need to be corrected
for to ensure radiotherapy treatment dose map accuracy [47, 49]. Whilst vendor supplied
correction algorithms reduce geometric distortions, they do not completely remove them.
As such, off-line corrections can be performed on images after they are acquired with de-
veloped correction techniques.
Distortion maps generated during the quantification of systematic distortion can be utilised
to correct for geometric distortions off-line [40, 47, 49–51, 56–61]. Another approach com-
bines phantom measurements and field-derived methods for quantifying and correcting dis-
tortions by measuring points along a restricted boundary and utilising spherical harmonics
to determine the magnitude of distortions. This combination has been found to give results
comparable to that of 3D grid phantom correction based methods [62].
Studies have also been performed to quantify and reduce geometric distortions resulting
from the presence of the patient within the magnetic field and the associated chemical shift
and susceptibility artefacts [63–65].
While these are viable correction techniques, they can be time consuming, may require a
lot of computing power and involve the manipulation of the images. Unfamiliarity with
MRI within a radiotherapy department may result in misunderstanding of the potential im-
plications that distortions may have on the treatment planning process. After the application
of vendor correction algorithms, residual distortions are still present and could impact the
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accuracy of the generated treatment if these distortions are not quantified and if large in
magnitude, left unaccounted for.
2.5 Role of MRI in radiotherapy treatment planning
The utilisation of MRI in the radiotherapy treatment planning process has increased signifi-
cantly over the last few decades. Okamoto et al. began investigating MRI scanners dedicated
to radiotherapy as early as 1993 [66]. Since then, many more centres have investigated the
utilisation of dedicated MRI scanners for RTP [39, 67–70]. Dedicated MRI scanners within
the radiotherapy departments enables MRI-simulation of the patient in the same way they
would in CT. It streamlines the workflow, with patients able to be imaged with minimal
movement between modalities.
Several questions can be asked when considering utilising a dedicated MRI scanner for
radiotherapy. These include:
(i) An open or closed bore scanner?
Devic summarises the benefits and limitations of open and closed bore systems for RTP
utilisation [71]. This summary suggests that an open bore configuration is the ideal
choice for MR imaging for RTP due to advantages in patient positioning and a more
uniform magnetic field. A limitation of such systems is the associated lower magnetic
field strength (see following point). Liney et al. highlight the recent development
of closed bore systems, making them a more viable option, with wider bore designs,
improved homogeneity and dedicated radiotherapy equipment [3].
(ii) A high or low field strength scanner?
There are benefits to high and low field scanners. Open bore scanners generally oper-
ate at lower field strengths (0.5 - 1 T), with the closed bore systems generally operating
at higher field strengths (1.5 - 3 T). Susceptibility and chemical shift artefacts are more
pronounced at higher field strengths (Section 2.4.2) and the higher the field strength
(namely 3 T), the risk of heating increases. However SNR increases in a linear fashion
with increasing field strength, allowing for improved soft tissue contrast and potential
improvements in delineation for the higher strength systems. Associated decreases in
scan times also reduces patient movement [20]. Imaging options including frequency
2.5. Role of MRI in radiotherapy treatment planning 20
selective fat suppression and MR spectroscopy have better performance on 3 T scan-
ners than lower strength systems [3]. The ideal field strength remains unknown, with
both low [39, 67, 70, 72, 73] and high [3, 25, 27, 69, 74–77] field options for MRI
simulation being pursued.
(iii) CT/MRI workflow or MRI-only workflow?
The benefits and limitations of each workflow are highlighted in Table 2.1 and sum-
marised in more detail in the sections below.
Table 2.1: Limitations of CT-MRI and MRI-only radiotherapy treatment planning work-
flows.
Workflow Benefits Limitations
CT-MRI Contains electron density informa-
tion
Ionising radiation delivered to pa-
tient during imaging
Short image acquisition time Time/movement of patient between
scans
Geometrically accurate Image registration required
MRI-only Superior soft tissue information No electron density information
Streamlined workflow Longer image acquisition time
No multi-modality image registra-
tion errors
Uncorrected geometric distortions
still present in planning image
2.5.1 Utilisation of MRI in a CT-based treatment planning work-flow
As well as geometric distortions, the lack of electron density information in MR images has
been a limiting factor in the widespread use of MRI for RTP. This is a key motivation behind
a combined CT-MRI workflow for treatment planning.
In a CT-MRI workflow, patient images are acquired on both modalities. The MRI provides
the superior soft tissue information beneficial for improved tumour and OAR delineation [2].
The CT provides the geometric gold standard representation of the patient anatomy with-
out the distortions and intensity variations associated with MRI and provides the electron
density information required for treatment planning dose calculations. The MRI and any
delineated structures are then registered to the primary CT dataset after image acquisition
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[78].
There are a number of different techniques that can be utilised for registering MRI and
CT images. These include manual, point-based, surface matching, chamfer matching and
feature-based registration techniques [35, 79]. A study by Dean et al. investigated the co-
registration accuracy of four CT-MRI registration techniques in patients with rectal cancer
[80]. They found that an automated registration technique performed the best, with the
results being able to be utilised in a radiotherapy workflow for prone rectal patient, with
an accuracy of within 2 mm. It should be noted however that these images are registered
by rigid body techniques, hence the MRI geometric distortions are still present and require
consideration.
Image acquisition and patient positioning are crucial to the CT-MRI workflow [81]. Ad-
equate immobilisation devices are required to ensure that the patient is in a reproducible
position, both for the image registration and treatment stages. Additionally acquisition pro-
tocols should be selected to ensure that there is no detrimental effect to the image registration
process (e.g. adequate pixel bandwidth to ensure that the susceptibility and chemical shift
effects are minimised).
If acquiring only MRIs for the planning process, the associated acquisition time could be a
limitation. MRI-only simulation would be more time consuming than that of conventional
CT simulation. If integrating MR images into a CT based workflow, the MR simulation time
could be reduced by acquiring large low-resolution images to obtain the overall anatomical
locations, followed by higher-resolution small FOV images, focusing on the anatomy of
interest for treatment [71]. The MRI and any associated anatomical contours delineated can
then be registered to the whole patient CT [82]. The combined structures from CT and MRI
can then be utilised in the planning process on the patient CT. Scanning at a smaller FOV in
the centre of the scanner also minimises the distortions that would be observed in the image,
particularly at the patient surface, which is further from the isocentre and prone to larger
geometric uncertainties.
Paulson et al. [83] conducted a large study over eight anatomical sites with a CT-MRI work-
flow. At least one large FOV scan was acquired for the purposes of MR to CT registration
via a six degree-of-freedom rigid body registration. This methodology incorporated strate-
gies appropriate for incorporating MR into CT-based RTP. While they see the possibility
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of having radiation oncology and diagnostic imaging work together to obtain the required
images, they highlight the advantages of having an MRI-simulator in the radiation oncology
department, even for a combined CT-MR RTP workflow. These include the ability to sched-
ule patient MRI simulation at the same time as CT, without large periods of time in between
and transportation of both the patient and any immobilisation equipment required.
2.5.2 Utilisation of MRI in a MR-only treatment planning work-flow
With the improved image quality of MRI, there is a push to remove CT from the planning
process altogether. This would streamline the RTP process for the patient, remove image
registration errors and reduce the ionising radiation delivered to the normal tissues from
simulation and verification imaging.
A number of groups have investigated ways of overcoming the lack of electron density infor-
mation in MR images to make MRI a viable stand-alone imaging modality for RTP. Since
the MRI can’t define density in the same way as CT, this information has to be assigned
(often referred to as substitute CT (s-CT) or pseudo-CT). One method involves manual or
automatic segmentation of images after which a uniform bulk-density is assigned to a given
segmented region [84–88]. These studies found the differences between bulk-density as-
signed and CT electron density information to be clinically insignificant for the anatomical
sites they investigated.
Other methods have been investigated to minimise potential errors due to inter-observer
variability and auto-segmentation errors. Dowling et al. have investigated atlas-based meth-
ods, where patient MR images are averaged to generate an atlas image and matching organ
labels which can be utilised to segment a new patient MR image [89]. A corresponding CT
atlas can then be generated and the appropriate electron density information be assigned.
Other studies have investigated an intensity-based approach whereby the tissues are char-
acterised by their intensity in the acquired images [90]. Gudur et al. developed a method
to derive electron density information combining both intensity and geometry information
from T1-weighted MR images using a unified Bayesian method in which two conditional
probability density functions of electron densities are calculated for each voxel [91]. Since
bone has a short T2 relaxation time relative to the other soft tissue structures, studies into
image acquisitions with ultra-short echo times (UTE) are being studied in order to be able
to segment bone for the RTP process [70, 90].
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Nyholm et al. investigated the uncertainties in both CT-MRI and MRI-only workflows for
prostate RTP [92]. The study concluded that a MR-only workflow was the most ideal, with
systematic uncertainties larger for the CT-MR methodology due to the associated systematic
errors throughout the treatment process introduced by the multi-modality image registration.
In a study conducted by Stanescu et al., a comparison was performed between CT-MRI and
MRI-only based treatment planning [93]. The results showed that the MRI-only method-
ology implemented performed similarly to the CT-MRI workflow and was a viable option
for treatment planning of the brain. This methodology included a correction of MRI distor-
tions, automatic segmentation of pre-defined structures and the assignment of bulk densities
to provide the CT information required for dose planning calculations.
2.5.3 Utilisation of MRI for radiotherapy image guidance
Image guided radiotherapy (IGRT) is common place in radiotherapy departments. Verifying
the patient setup and variations due to tumour growth or reduction during treatment are cru-
cial for ensuring accurate treatment delivery. If MRI is to be the primary imaging modality
for RTP, MRI guidance systems would be a requirement [27]. The required technology has
come a long way and continues to develop in order to achieve this [26].
There are several systems available for MRI-guided radiotherapy. Jaffray et al. have devel-
oped an MRI guidance facility based on a MRI on rails system with a 1.5 T scanner and a
separate linear accelerator [21]. The ViewRay system is a commercially available system,
integrating a 0.35 T MRI scanner with a Cobalt-60 radiation treatment unit [22].
Several systems are being developed incorporating a MRI scanner and a linear accelerator
into one system. Lagendijk et al. are developing a fully integrated 1.5 T MRI scanner with a
6MV linac [25, 94]. Fallone et al. are investigating a rotating system combining a 0.6 T MRI
scanner and a 6MV linac waveguide placed either perpendicular or parallel to the magnetic
field [23, 95]. Keall et al. are proposing the combination of 1 T open bore MRI with a 6MV
linac inline or perpendicular to the magnetic field with 3 different configurations: 1) fixed
beam/horizontal rotating patient; 2) fixed beam/sitting or standing rotating patient; and 3)
rotating beam and magnet [24].
As patients undergo radiotherapy, their bodies respond and change throughout the course
of treatment. Changes in tumour volume size, daily organ shifts and/or patient weight are
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examples of where differences in the simulated and daily anatomical geometry can have
a profound impact on the patients treatment. Improvements in image guidance technol-
ogy, such as these MRI-linac systems will allow for the individualised treatment adaptation
throughout the course of radiotherapy, to ultimately improve the outcome for the patient
[27].
MRI can also enable the monitoring of tumour response throughout the course of a patients
treatment [20, 29–31]. This is beneficial in determining how to proceed with the treatment,
if the tumour is well responding to the radiotherapy, or when response is poor modifying the
course of treatment accordingly. Diffusion weighted imaging (DWI) is an imaging technique
which can be used for this purpose, monitoring the tissue-water mobility between tumours
and normal tissues (where tumours will exhibit larger restrictions in the motion of water
molecules due to the high cellularity of the tumour volume) [96].
2.6 Impact of MRI distortion in radiotherapy
Investigations into the dosimetric impact of MRI geometric distortions in RTP have focused
primarily on brain and prostate patients. For these sites, under the specified study conditions,
MR distortions were not found to have a significant impact on dosimetry. Since the brain is
located in a small FOV at the centre of the scanner, the observed distortions are minimal and
gives dosimetric results similar to that obtained with CT treatment plan generation [32, 76,
97]. The prostate studies were conducted on low magnetic field strength scanners [73, 98],
with no corresponding patient CT data over a small cohort [99], or on phantom geometry
[77].
These studies previously investigated represent anatomical sites which the target and or-
gan at risk volumes lie predominately in the central regions of the FOV where geometric
distortions should be at a minimum. Anatomical sites in which the treatment volume lies
in regions of higher geometric distortions (further away from the isocenter of the scanner)
could potentially have a more significant impact on the treatment planning process.
The breast represents an anatomical location which lies further from the isocentre of the
MRI scanner and may be subject to larger geometric distortions. Prott et al. [100] suggest
that geometric accuracy implications for RTP of anatomical sites further from the scanner
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isocentre including the breast, be investigated in greater detail. Based on their virtual plan-
ning study, Prott also emphasises that variations in dose between planned and treated dose
distributions to OAR structures indicate that distortions should be evaluated on a patient
specific basis. Breast radiotherapy treatment planning will be investigated in this thesis.
Chapter 3
Quantifying MRI distortion with a 2D
distortion phantom
3.1 Introduction
There is a growing interest in utilising MRI for radiotherapy treatment planning (RTP). One
of the main reasons for this is the superior soft tissue information that MRI can provide,
improving the differentiation between various soft tissue structures and increased accuracy
in volume delineation [2, 98]. One of the potential issues in the radiotherapy community
impacting on the more widespread uptake of MRI for RTP is geometric distortion within
the image [32]. Changing the geometric integrity of the patient anatomy has the potential to
affect the precision of beam targeting and dose calculations within radiotherapy treatment
planning systems. This has the potential to result in variations in clinical outcomes. These
distortions are caused by both system specific and patient related factors.
System specific distortions result from variations in the homogeneity of the main magnetic
field (B0) and the nonlinearities of the gradient fields within the scanner (see Section 2.4).
Altering parameters in the image protocol alters the dependence of the acquisition on the
gradient coils, altering the distortion present in the image, based on the imperfections in
these features. The effects resulting from these intrinsic scanner components alone are re-
producible for the same scan protocols, whilst varying between scanners due to variations
in system specifications and performance [40].
1Part of this chapter has been published:
Walker A, Liney G, Metcalfe P, Holloway L. MRI distortion: considerations for MRI based radiotherapy
treatment planning. Australian College of Physical Scientists and Engineers in Medicine 2014; 37(1):103-113
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The gradient coils allow for the localisation of a signal from within the body, enabling the
anatomy to be visualised. Images are constructed on the premise that these gradients are
linear and there is a homogeneous main magnetic field (B0). In modern scanners there is a
trade-off in gradient linearity to allow for utilisation of fast imaging sequences and stronger
gradient strengths. Whilst such advances can reduce the effects of patient movement and
increase patient comfort, the geometric distortions may be greater due to these gradient
nonlinearities. This causes a mismapping of pixels, affecting the geometrical integrity of
the resulting image. General specifications for scanner body gradient coils are that the gra-
dient error should be less than 2% the gradient strength over a 40 cm diameter of spherical
volume (DSV)[37]. Performance specifications of additional gradient coil inserts are char-
acteristically less than this, which can lead to increased nonlinearity effects [37].
The B0 field homogeneity is another system property which can alter the distortion present
in images. Main field homogeneity is measured in parts per million (ppm) over a DSV
extending out from the scanner isocentre. Homogeneity values for current scanners are typ-
ically 1.1 ppm across a 50 cm DSV. For a 1.5 T scanner, this corresponds to a frequency
offset of 70.2 Hz. For an image acquired with a pixel size of 1 mm x 1mm and an imaging
BW of 220 Hz/pixel, this equates to a geometric shift of 0.32 mm. Such homogeneity vari-
ations can create discrepancies in signal location and manifest as image intensity variations
and residual distortions within the image.
There have been a number of different methods proposed for dealing with nonlinear gradient
distortions for use in RTP. Many of these methods are based on obtaining phantom images
with a known geometry and comparing the apparent position of structures within the MR
image to the known point locations to create a distortion map across the field of view (FOV)
[49, 50, 52, 58, 101]. After this, post-processing can be conducted in order to correct for
the residual distortion based on these maps with the aim to reduce distortions below 2 mm.
Distortions greater than this may need to be corrected for to meet the tolerance limits for
imaging in radiotherapy [54], in order to ensure accurate radiotherapy treatment [47, 49].
Any residual distortions would need to be considered when determining planning volumes
to ensure that the target volume is covered [102]. This would depend on the location of
the anatomical site and the magnitude of the distortions observed within that region of the
scanner.
A more theoretical approach can be utilised by applying spherical harmonic deconvolution
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methods to correct for distortions within a specific device’s FOV [55]. This method is the
basis for the correction algorithms utilised on some commercial scanners and also includes
a density correction for intensity variations caused by these distortions [47].
While distortions are unwanted in any image, their impact is dependent on how the images
are utilised. This chapter evaluates geometrical inaccuracy with respect to the application
of images for RTP purposes. A number of studies have investigated the geometric accuracy
of clinical MRI scanners for the purposes of RTP [39, 49, 103, 104]. Previous studies of
MRI distortion investigating the use of MRI for radiotherapy for a number of anatomical
sites have focused on one specific acquisition sequence [40, 46, 49–51, 58, 60, 73, 101].
These studies were also focused on anatomical locations which would be placed close to the
centre of the scanner such as the prostate [49, 73, 98], head and neck [47, 64, 76] as well as
stereotactic radiosurgery applications [45].
In this study, images of a test phantom were obtained in one imaging plane using a number of
different clinical MRI protocols with varying selection parameters. Four MRI scanners from
different centres were investigated. Differences in magnitude and direction of the distortion
between scanners and imaging protocols were assessed. This data was then compared to the
location of anatomical sites which may be of interest when considering the use of MRI in
RTP. This study also investigated the effects of varying bandwidth (BW) on distortion and
the signal-to-noise ratio (SNR). By acquiring images at two different bandwidths it was also
possible to estimate the homogeneity using the method described by Chen et al. [105]. This
study only considered distortions from systematic factors. Patient related distortions were
not addressed.
3.2 Method
3.2.1 Phantom
To determine the distortion magnitude and pattern, MR images of a FLUKE Biomedical
phantom were acquired (Figure 3.1). This commercially developed phantom conforms to
the specifications as outlined in the AAPM nuclear magnetic resonance task group number
1 [106]. It is designed to enable the testing of uniformity and linearity of MRI scanners. The
acrylic phantom has outer dimensions of 330 mm x 330 mm x 102 mm, with the grid region
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Figure 3.1: From left to right: the phantom used for this study, CT scan of the phantom and
a turbo spin echo image of the phantom.
of dimensions 277 mm x 277 mm x 25 mm. Contained within this were 397 cylindrical
grid points in a 20 x 20 2D grid layout, with three points removed for consistent orientation
and alignment. The spacing between the axial centres of each grid point is approximately
15 mm, with each grid point having a diameter of 12 mm. The grid points were created
by systematically placed holes milled into the acrylic structure. The holes were filled with
saline to create the 2D grid pattern. The centre of the phantom was aligned in the horizontal
direction to the centre of the scanner. The vertical position of the phantom was determined
by the fixed couch height of each scanner.
3.2.2 Phantom imaging procedures
CT
A CT scan of the phantom was undertaken on a Siemens SOMATOM Sensation scanner.
This was taken to be the ‘gold standard’ scan, assumed to have negligible distortion for
determining the grid point locations. Scan parameters included a FOV of 500 mm, 512 x
512 matrix (spatial resolution 0.98 mm) and a slice thickness of 2 mm.
MRI
Measurements were made on four clinical MRI scanners, a 60 cm bore Intera Achieva Nova
Dual 1.5 T (Philips Medical Systems, The Netherlands), a 60 cm bore MAGNETOM R© Sym-
phony Syngo 1.5 T, a 70 cm bore MAGNETOM R© Verio 3 T and a 70 cm bore MAGNETOM R©
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Skyra 3 T (Siemens Medical Systems, Erlangen, Germany). A number of sequences were
investigated based on their clinical applications for radiotherapy treatment planning. Table
3.1 shows the acquisition details for each of these sequences. The sequences were matched
as closely as possible on the different MRI scanners for comparative purposes.
To ensure set-up reproducibility on different scanners, round MRI compatible multi-modality
markers were fixed to the sides of the phantom and the laser system on the scanners used
to align these markers to the scanner isocentre. Analysis of both CT and MR images were
conducted on the axial image slice corresponding to the centre of the scanner and the central
region of the phantoms grid structure. To overcome the issue of the rounded/padded couch,
one of two approaches was taken, depending on the scanner.
For the Siemens 3 T Verio and the Philips 1.5 T scanners, the phantom was placed on a
flat Styrofoam board to ensure its stability on the couch. The spine coil was removed on
the Siemens 1.5 T Symphony and 3 T Skyra scanners, allowing for stable placement of the
phantom as well as creating better alignment between the phantom centre and the scanner
isocentre. The position of the phantom with respect to the scanner isocentre was noted
so that all distortion measurements could be made with reference to the distance from this
point. The vertical position of the phantom was dependent on the couch height.
For both the Siemens 3 T scanners, there was an option in the acquisition setup allowing
for application of inbuilt gradient correction algorithms. The 2D algorithms were applied
on these scanners, since the phantom design meant that distortion could only effectively be
measured within a 2D imaging plane. For comparative purposes on the Siemens Verio 3
T scanner, phantom images were also analysed without the application of the 2D gradient
correction algorithm. The images were initially acquired with the algorithm turned on. Once
all of the sequences had been acquired and saved, non-corrected images were then obtained
through post processing methods, by deselecting the 2D algorithm option in the control
panel and re-saving the image sets. The corresponding changes in distortion between the
two modes of acquisition could then be determined. Not all scanners had the capability
of applying 3D distortion corrections so only the 2D correction algorithms were assessed.
Additionally, only a thin section of the phantom in the axial plane at isocenter was analysed
and hence the impact of distortion correction in the slice-selection direction was considered
to be minimal for these measurements.
3.2. Method 31
Table 3.1: Parameter of the MRI acquisition sequences for which distortion was assessed
Scanner Sequence Image
weight
2D/
3D
TR/TE
(ms)
FOV
(mm)
Flip
angle
(o)
Slice
thickness
(mm)
Pixel
BW
(Hz/pix)
Philips
1.5 T
Intera
Achievaa
Spoiled
GRE
Spoiled
GRE
V-Interp
GRE
V-Interp
GRE
SS-TSE
3D TSE
TSE
T1
T1
T1
T1
T2
T2
T2
3D
2D
3D
3D
2D
3D
2D
25/4.6
2.6/4.6
7.0/4.8
4.3/2.1
1500/
120
2000/
350.8
4012.9/
100
450x450
450x450
450x450
450x450
450x450
450x450
450x450
30
80
9
9
124
120
90
3
3
4
4
4
5
4
131
1818
434
434
355
417
191
Siemens
1.5 T
Symphony
Syngob
Spoiled
GRE
Spoiled
GRE
SS-TSE
3D TSE
TSE
TSE
3D SE
T1
T1
T2
T2
T2
T2
T2
3D
2D
2D
3D
2D
2D
3D
7.2/2.8
139/
2.32
1890/
115
1820/
471
4550/
127
4550/
127
9.4/4.8
450x450
450x450
450x450
420x420
450x450
450x450
420x420
20
70
120
120
120
120
20
1.3
4
4
2.5
4
4
5
175
390
115
125
85
85
150
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Table 3.1: Parameter of the MRI acquisition sequences for which distortion was assessed
Scanner Sequence Image
weight
2D/
3D
TR/TE
(ms)
FOV
(mm)
Flip
angle
(o)
Slice
thickness
(mm)
Pixel
BW
(Hz/pix)
Siemens
3 T
Verioc
Spoiled
GRE
Spoiled
GRE
V-Interp
GRE
V-Interp
GRE
SS-TSE
3D TSE
TSE
T1
T1
T1
T1
T2
T2
T2
3D
2D
3D
3D
2D
3D
2D
6.0/2.5
167/
2.5
4.4/2.5
4.6/2.0
1890/
119
1280/
90
5030/
81
450x450
420x420
450x365
450x450
450x450
450x450
450x450
20
70
9
9
120
120
80
1.3
4
3
2
4
2.5
4
399
279
679
401
507
244
228
Siemens
3 T
Veriod
Spoiled
GRE
Spoiled
GRE
V-Interp
GRE
V-Interp
GRE
V-Interp
GRE
SS-TSE
TSE
T1
T1
T1
T1
T1
T2
T2
3D
2D
3D
3D
3D
2D
2D
5.7/2.5
90/
2.5
4.2/2.4
4.4/2.1
4.4/1.2
900/
87
4780/
81
340x340
340x340
380x368
340x340
380x380
340x340
340x340
20
70
9
9
9
120
80
3
4
3
2
3
3
3
390
280
675
400
975
505
230
GRE = Gradient Echo; V-interp = Volume interpolated
TSE = Turbo Spin Echo; ss-TSE = Single Shot Turbo Spin Echo
a Maximum gradient strength 66 mT/m, slew rate 160 T/m/s
b Maximum gradient strength 30 mT/m, slew rate 125 T/m/s
c Maximum gradient strength 45 mT/m, slew rate 200 T/m/s
d Maximum gradient strength 45 mT/m, slew rate 200 T/m/s
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3.2.3 Distortion analysis
MATLAB code was developed in-house and implemented to determine the position of each
phantom grid point in the x and y plane. Each image was converted into a binary image by
manually altering the threshold value so that all grid points could be differentiated from each
other and any noise present in the image. The code was designed to calculate the central po-
sitions of each of these points. The distortion for each grid point was expressed as a function
of its radial distance from scanner isocentre by comparing the positioning of the centre of
the phantom relative to isocentre. Comparisons of distortion magnitude and patterns from
isocentre were then undertaken for all sequences and scanners. The distortion magnitude
was assessed relative to an assessment criterion of 2 mm. The 2 mm criterion is taken from
image accuracy requirements for radiotherapy simulation [43]. Also, the accuracy of the
distortion measurement will be limited by the voxel size used to acquire the images, hence
2 mm is a reasonable relative measurement.
3.2.4 Bandwidth Investigation
The effects of changing bandwidth on the distortion and signal to noise ratio (SNR) follow
the relationship displayed in equation 3.1:
SNR ∝ 1√
receiver bandwidth
∝ Distortion (3.1)
Scans were conducted on the Siemens 1.5 T MAGNETOM R© Symphony Syngo scanner, for
both visual and quantitative analysis of this relationship. The acquisition sequence utilised
was a standard T1 weighted spin echo with TE = 30 ms, TR = 500 ms, FOV = 340 x
340 mm, slice thickness = 4 mm and echo train length = 1. The impact of varying both
the bandwidth and the phase encoding direction was assessed to investigate variations in
distortion patterns and magnitudes. The receiver bandwidths investigated were 7.7, 25.6,
51.2, 76.8 kHz and 200 kHz with the readout gradient tested both in the anterior-posterior
and right-left directions for each bandwidth value.
The impact on SNR with changing bandwidth was calculated from equation 3.2:
SNR = average signal
std.deviationofbackground
(3.2)
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The signal was calculated for each bandwidth by analysing twenty predetermined grid point
regions of interest (ROI’s) selected across the phantom area. The image noise was also
sampled with ROI’s of the same size across the background of each image.
3.2.5 Homogeneity assessment
The homogeneity of the scanners B0 field is another system property which can alter the
distortion present in images. Main field homogeneity is measured in parts per million (ppm)
over a DSV extending out from the scanner isocentre. Homogeneity values for current
scanners are typically 1.1 ppm across a 50 cm DSV. For a 1.5 T scanner, this corresponds
to a frequency offset of 70.2 Hz. Such homogeneity variations can create discrepancies in
signal location and manifest as image intensity variations and distortions within the image.
The homogeneity of the central scanner region was assessed across a range of different
areas across the central imaging plane of the scanner. Comparisons were made between the
differences in distortion values for narrow and wide bandwidth values. This was tested on
the Siemens 1.5 T scanner. This was based on the work of Chen et al., utilising the following
for expressing HB [105]:
HB(ppm) =
BW 1 ·BW 2 · (x′1 − x′2)
(γ/2π) ·B0 · FOV · (BW 2 −BW 1)
(3.3)
where γ/2π = 42.576 MHz/T for protons, BW1 and BW2 are the bandwidths of the data
sets being compared, x1 and x2 are the coordinates in the frequency encoding direction of
corresponding grid points for each bandwidth, B0 is the main magnetic field strength and
FOV is the field of view. The values were determined for a number of circular areas of
varying diameters within the imaging plane.
3.2.6 Anatomical locations
Seven anatomical sites of interest for radiotherapy treatment planning were investigated to
determine their common location with respect to the distance from the centre of both 60 cm
and 70 cm bore MRI scanners. Contoured radiotherapy CT data sets of the breast, lung,
oral cavity, larynx, brain stem, prostate and cervix were obtained for ten patients. In-house
MATLAB code was utilised to determine the coordinates of the centre and extent of each
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contoured volume in the x and y planes.
The maximum radial distance that each anatomical contour extended from the scanner
isocentre was recorded. It should be noted that the head and neck structures were based on
CT scans obtained with the clinical radiotherapy set up practised in the department where
the region is elevated off the couch top.
3.3 Results
3.3.1 Sequence and scanner distortion comparison
Figures 3.2 and 3.3 compare the distortion distribution for the different sequences and scan-
ners investigated. The average distortion of the markers across the phantom area was less
than 2 mm for the sequences tested. An increase in distortions above 2 mm generally oc-
curred as the radial distance from isocentre extended beyond 100 mm. Due to the variations
in bore size, the phantom was located closer to the edge of the bore, extending further from
the isocentre in the 60 cm bore scanners in comparison to the 70 cm.
3.3.2 Bandwidth analysis
Table 3.2 shows the variation in average and maximum distortion values for the various re-
ceiver bandwidth values and the corresponding readout direction. The SNR for bandwidths
between 7.68 kHz to 76.8 kHz decreased by a factor of 3.1, (theoretical value = 3.2 for a
tenfold increase in BW). Bandwidths greater than 76.8 kHz were not assessed due to the
poor signal to noise observed in the images. For a bandwidth of 200 kHz, the SNR was
reduced to 3.7, preventing the calculation of grid point locations. The homogeneity of the
scanner was less than 0.4 ppm across areas with diameters ranging from 12 cm to 20 cm.
On the 1.5 T scanner, a variation of 0.4 ppm in the magnetic field strength accounts for a
distortion of 0.85 pixels for a bandwidth of 7.68 kHz. In these images, that equates to 1.13
mm distortion. For a receiver bandwidth of 76.8 kHz, this value is reduced to a distortion of
0.08 pixels (0.11 mm).
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Table 3.2: Comparison of the effects on the distortion values measured across the phantom
for variations in the receiver bandwidth and phase encoding direction
Bandwidth
(kHz)
Phase encode
direction
Avg distortion
(mm ± SD)
Maximum
distortion (mm)
SNR
7.7 Ant - Post 2.16 ± 1.66 6.33 ± 0.66
7.7 Right - Left 2.21 ± 1.48 5.27 ± 0.66 20.01
25.6 Ant - Post 0.80 ± 0.57 3.00 ± 0.66
25.6 Right - Left 0.68 ± 0.45 2.16 ± 0.66 11.29
51.2 Ant - Post 0.77 ± 0.44 2.23 ± 0.66
51.2 Right - Left 0.59 ± 0.37 1.96 ± 0.66 7.69
76.8 Ant - Post 0.60 ± 0.36 1.93 ± 0.66
76.8 Right - Left 0.60 ± 0.37 1.74 ± 0.66 6.54
3.3.3 Vendor 2D corrected vs. non-corrected images
Figure 3.4 shows the variations observed in changes in distortion magnitude and distribution
across the phantom area with the application of the 2D correction algorithm for both a spin
echo and gradient spin echo sequence. With the correction algorithm, both the average
and maximum distortion values were minimised in some areas but were not completely
removed. In some regions of the phantom, the distortion actually became worse with the 2D
correction algorithm applied as opposed to without. Whilst the average distortions across the
phantom area were all reduced to below 1.5 mm with the correction algorithm, the maximum
distortions still remained greater than 2 mm, increasing with increasing distance from the
isocentre. The performance of the correction algorithm with respect to radial distance from
the scanner isocentre is highlighted in table 3.3.3. Figure 3.5 shows a distortion vector
map comparing the difference in distortion between the grid point locations as seen with
and without the correction algorithm applied. This shows the algorithm is not required to
provide much correction for smaller radial distances where distortions were generally found
to be below 2 mm.
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Table 3.3: Comparison of the variation in mean and average distortions observed for radial
distances above and below 100 mm radial distance from the scanner isocenter
Sequence Mean distortion
Below 100 mm
Mean distortion
Above 100 mm
Max distortion
Below 100 mm
Max distortion
Above 100 mm
3D TSE
- Corrected 0.53 1.09 1.32 2.81
- Non Corrected 0.47 1.86 1.19 4.41
3D spoiled GRE
- Corrected 0.61 1.01 1.68 2.34
- Non Corrected 0.56 2.03 1.37 5.00
3.3.4 Anatomical locations
Figure 3.6 displays the distortion obtained on both Philips and Siemens T2 weighted turbo
spin echo sequences with reference to the determined mean locations of the breast, lung,
cervix, prostate and head and neck structures relative to the isocentre within a 2D axial
imaging plane. The length of each represents the regions where each anatomical feature
lies with respect to the centre of the scanner. The breast was the only anatomical structure
investigated where the contour did not pass through the scanner isocentre.
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Figure 3.2: Distortion distribution across the phantom area on the 1.5 T scanners for a.
Philips Intera gradient echo sequences; b. Siemens Syngo gradient echo sequences; c.
Philips Intera spin echo sequences; and d. Siemens Syngo spin echo sequences.
Figure 3.3: Distortion distribution across the phantom area on the 3 T scanners for a. the
Siemens Verio gradient echo sequences (2D correction applied); b. Siemens Skyra gradi-
ent echo sequences (2D correction applied); c. Siemens Verio spin echo sequences (2D
correction applied); and d. Siemens Skyra spin echo sequences (2D correction applied).
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Figure 3.4: Comparison of the distortion distribution across the phantom area with and
without the application of the 2D correction for a. 3D turbo spin echo sequence and; b. 3D
spoiled gradient echo sequence.
Figure 3.5: Difference between 2D distortion maps of a 2D spoiled gradient echo sequence
on a Siemens Verio 3 T scanner with and without the 2D correction algorithm applied.
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Figure 3.6: The distortion observed from the radial distance from the centre of a. the Philips
1.5 T 60 cm bore scanner with the TSE sequence and; b. the Siemens 3T 70 cm bore Verio
scanner. The blocks indicate the corresponding position of anatomical sites within the scan-
ner. Note the scale has been extended out to illustrate where the breast is situated, although
distortion measurements were not made beyond a radial distance of 250 mm. NOTE: The
height of each box is for display purposes only and does not reflect any information regard-
ing the distortion values.
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3.4 Discussion
Each MRI acquisition sequence was demonstrated to be subject to individual distortion pat-
terns as shown in Figs. 3.2 and 3.3. Parameter selection impacts the amount of distortion
in an image. Equivalent sequences conducted on different scanners have varying distor-
tion patterns. This is due to the system hardware design specification variations between
vendors.
MRI scanners are optimised to exhibit least distortion towards the centre of the scanner, with
the homogeneity and gradient linearity deteriorating with increasing radial distance from the
centre. In this study, the phantom extended closer to the edge of the bore for the 60 cm bore
scanners than those with 70 cm bores, due to the size limitations and fixed couch height.
This was one of the reasons for the variations seen in the maximum distortions observed
between the 60 and 70 cm bore scanners, all of which are capable of imaging a 50 x 50 cm
FOV. This set up was the same as that used for current radiotherapy treatment planning MRI
scans.
Receiver bandwidth is one parameter that effects MR image distortion as shown in table 3.2
A tenfold increase in receiver bandwidth saw a reduction in average distortion of more than
1 mm, while maximum distortions were reduced by more than 3 mm. A tenfold increase in
this bandwidth resulted in a reduction in SNR by a factor of 3.1. To overcome this reduction
in SNR, the number of excitations during the image acquisition could to be increased. This
may be a solution for phantom studies however applying this to the acquisition of patient
images may not be practical with a resulting increase in total scan time and associated in-
crease in motion artifacts. While smaller receiver bandwidth values result in better SNR,
higher bandwidths result in less geometric distortion.
The homogeneity values obtained were based on the calculation method from Chen et al.
[105]. The HB value calculated of < 0.4 ppm across the scanner is consistent with the
scanner specifications, which state the homogeneity across a 40 cm DSV is 0.4 ppm with a
field stability of < 0.1 ppm/hour. One of the assumptions made in the calculations however,
is that the gradients are linear, which is not the case particularly as the DSV increases.
For treatment planning purposes, vendor correction algorithms for gradient nonlinearities
should be utilised on scanners with such capabilities in order to take advantage of their in-
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built distortion reduction software. Figures 3.4 and 3.5 show the difference in distortion
values for images acquired with and without the correction algorithms applied, across the
phantom area. It can be observed that in some regions both the magnitude and direction of
the distortion is altered with the application of the correction algorithm, though the distor-
tions were not completely removed.
One of the limitations of this study was the phantom utilised due to its shape and size.
Firstly, because of the square shape within the cylindrical bore, there was a large region of
the scanner, where distortion information could not be assessed. Since some patient anatomy
(e.g. breast) may lie beyond this point, the phantom was insufficient for complete distortion
analysis for RTP purposes. Secondly, the 2D grid structure only allowed for distortion
assessment in one imaging plane. On scanners with distortion correction capabilities, the
2D correction algorithm was applied. Due to the phantoms structure, application of a 3D
correction algorithm provided no additional benefit in terms of distortion reduction within
the imaging region. The phantom was not rotated within the scanner to obtain 2D distortion
data within other imaging planes.
A phantom for testing geometric distortion and field homogeneity would ideally consist of
a number of points isolated in known positions in all three image planes, extending out over
the entire FOV. This would be more representative of the regions within which the overall
patient outline and anatomical regions of interest for RTP would be located. Assessment of
patient specific distortions (which have not been investigated in this study) would require
the testing of additional anthropomorphic phantoms or patient data sets to determine the
consequential variations in the local magnetic field values.
The variation in distortion distribution for clinical imaging sequences as observed in Figures
3.2 and 3.3, demonstrates the importance of knowing the scanner specifications and the
protocols used in the imaging process for use in RTP. Considerations should be made as to
the possible effect that this may have on contouring uncertainties and dosimetric variations.
In a clinical setting, these acquisition parameters are readily changeable in order to obtain an
image of required quality for the purposes of planning, however the trade-offs between SNR
and distortion values need to be considered. It was assumed for each acquisition sequence,
with the same setup that the distortion values were reproducible [107].
The distortion maps in Figures 3.2 and 3.3 can be compared to the position within which
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various clinical sites lie with respect to the centre of the scanner (Figure 3.6). Since dis-
tortions are largest in the peripheral regions of the scanner, the impact on RTP may be of
greater importance for anatomical structures situated in this region. Based on anatomical
positioning within the scanner, treatment planning for the lung and breast clinical sites us-
ing MR images would have the largest distortion values to be considered. The distortions
present in head and neck images would need to be considered, since the oral cavity may be
a target volume or organ at risk. Patient contours are fundamental in the treatment planning
process for the dose calculations. As such the extent of the patient within the scanner needs
consideration. For breast patients, the breast contours also mark the extent of the patient
contour. For the prostate and cervix, the overall patient contour can extend beyond a radial
distance of 200 mm. For head and neck sites, the region of interest for the patient contour is
reduced to below a radial distance of 150 mm from isocentre.
While MRI can be co-registered to the planning CT and incorporated in the RTP workflow
[71], there is widespread interest in performing MR-only planning. MRI-only planning has
the potential to decrease the ionising radiation exposure to the patient and, if both modal-
ities are being utilised, the patient scan time. Additionally, CT-MRI registration may also
introduce errors into the treatment planning process. Assessment of the geometric distortion
is one important aspect to investigate when considering the use of MRI alone for planning,
to ensure that the planning process and eventual treatment are accurate.
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3.5 Conclusion
A baseline assessment of variations in magnitude and distribution of systematic distortions
present in MR images was conducted. Differences between sequences and MRI scanners
were observed, the largest variations occurring between scanners. These are due to the
parameters utilised in the acquisition process (with the largest influences being from the re-
ceiver bandwidth selected and the application of vendor supplied correction algorithms) and
the specific B0 and gradient characteristics of each individual scanner. Differences in dis-
tortion patterns were observed between acquiring the images with the phase and frequency
encoding directions, a observation that will be utilised in investigations discussed in Chapter
5. The selection of imaging protocols and parameters, as well as understanding the scan-
ner geometric limitations is fundamental when considering the use of RTP planning with
MRI alone. The magnitude of distortions varies across the imaging FOV such that depend-
ing on the clinical site of interest, site specific assessment of the possible clinical impact is
important and off-line correction of these distortions investigated if required.
The AAPM report 100 [43] states that comprehensive distortion mapping of each system is
recommended to determine the tolerances and constraints to minimise MRI distortion im-
pact for RTP or provide data for a correction scheme where appropriate. While the MRI test
2D phantom utilised gave a good initial indication of the scanners geometric integrity and
relative scanner performance, it was not adequate for full distortion assessment as recom-
mended and was limited in the extent to which the distortion could accurately be measured
across the whole FOV.
Chapter 4
Development of a 3D distortion phantom
4.1 Introduction
Phantom based measurements are a common method to quantify MRI geometric distortion
by comparing the known location of features within the phantom to the apparent location
in the MR image. Many commercially developed phantoms are designed to test multiple
imaging parameters such as geometric distortion, uniformity, resolution, chemical shift, sig-
nal to noise (SNR) and ghosting. As a result, each phantom test element is relatively small.
A number of distortion studies have been conducted with such phantoms [44, 45, 55, 108].
Such phantoms are often used for QA of diagnostic MRI scanners, as opposed to that of
MRI-simulators used in radiotherapy treatment planning, where higher geometric precision
is required. Limitations included the restricted FOV coverage and the number of control
point locations at which the distortion can be determined. Several studies have developed
their own distortion phantoms, tailored to specific applications [48, 58, 109–111]. It was not
always necessary for these studies that a full distortion assessment be performed. For the
purposes of RTP investigations many of these phantom designs were unsuitable, often be-
ing limited in size, shape and were often plagued by air bubbles and potential susceptibility
artifacts where the liquid solution being used met the phantom housing structure.
Chapter 3 highlighted the limitations of a commercial phantom in terms of its ability to
adequately determine distortion across all 3 imaging planes and the limited ability to cover
1Part of this chapter has been published:
Walker A, Liney G, Holloway L, Dowling J, Rivest-Henault D, Metcalfe P. Continuous table acquisition
MRI for radiotherapy treatment planning: distortion assessment with a new extended 3D volumetric phantom.
Medical Physics 2015; 42(2):1982-1991
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the FOV required for imaging the region of the body required for RTP purposes. In such
a case, full FOV distortion assessment would involve moving small phantoms around the
scanner volume, introducing issues in reproducibility of placement and changes in field
inhomogeneities with the changing phantom position. This chapter identifies key phantom
characteristics when physically measuring MRI distortion for applications in radiotherapy.
Numerous prototypes were investigated before the final phantom design was developed. The
new 3D phantom is capable of characterising whole FOV distortions as required for RTP.
The design presented is novel due to its extended length and the use of numerous offset
vitamin E capsules, rather than rods for the assessment of through-plane distortion.
4.2 Prototype Development
4.2.1 Assessment Criteria
A number of ideas for assessing the geometric distortion in MR images were investigated,
with the end result to design a phantom appropriate for the purposes of RTP. Prototypes
were developed for this purpose. Each prototype was assessed based on the criteria in table
4.1. All of these ideal criteria needed to be met before the final phantom was developed.
Table 4.1: The criteria required for the phantom development and the associated method of
assessment.
Criteria Method of Assessment
MRI compatible Initial condition was set that any design must be possi-
ble without the need for ferromagnetic materials
Grid points localised in 3 dimensions The coordinates of the grid points needed to be read-
ily defined in all 3 imaging planes in the design stage
across the whole phantom area
Full FOV coverage For radiotherapy, whole patient images usually ac-
quired with x-y FOV 500 x 500 mm with a scan length
> 250 mm. The phantom dimensions needed to be ca-
pable of such measurements
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Table 4.1: The criteria required for the phantom development and the associated method of
assessment.
Criteria Method of Assessment
Practical design The phantom had to be as lightweight as possible (ac-
counting for the required size), with appropriate meth-
ods for handling. It was required to be readily trans-
ported between MR and CT for imaging with solid
components to avoid any major leaks/spills in trying to
contain fluids in the large quantity required
CT AND MRI visualisation Acquisition of images on CT and/or MRI. Good con-
trast required on both imaging modalities
Initial prototypes were developed using ideas derived from the literature as well as commer-
cial materials that were readily available in the department. Figure 4.1 shows the prototype
development process in arriving at a design solution that met our needs, as specified by the
predefined assessment criteria. The final phantom design was developed further based on
the prototype designs that had met all of these specified criteria.
4.2.2 Prototypes
1. Anthropomorphic phantom
The thorax and breast sections of an anthropomorphic phantom (CIRS female ATOM
dosimetry phantom) (Figure 4.2) were used to investigate the feasibility of utilising a
pre-existing radiotherapy department phantom. These phantom components had to-
tal cross section dimensions of 20 cm x 25 cm (including the breast attachments).
The phantom design included removable plugs (5 mm diameter x 25 mm length)
where, when removed, various types of dosimeters can be placed throughout. Gela-
tine, wax candles, lard, a radiotherapy bolus material and a gadolinium (Gd) solution
were placed within these holes to determine if certain materials would be feasible and
practical for examining distortion in MR images. These materials (excluding the solid
wax candles) were placed into straws for containment and easier placement within the
phantom (Figure 4.3).
2. Lego R©
4.2. Prototype Development 48
Figure 4.1: The development process of phantom prototypes. Progression was based on the
conformity to the acceptance criteria.
Figure 4.2: Anthropomorphic phantom used (with breast attachments filled with signal pro-
ducing materials).
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Figure 4.3: Lego and straws filled with lard and gelatine for containment and ease of place-
ment within the anthropomorphic phantom.
The known geometry of Lego R© blocks was utilised in the next prototype. Similar
studies have conducted small scale investigations [110, 111]. Rather than immersing
the Lego R© blocks within a solution as previous studies had done, the cavities under
blocks were filled with lard or gelatine as with the previous prototype (Figure 4.3), to
investigate how these materials showed within this known geometric structure.
3. Styrofoam and water
Dow Styrofoam (extruded polystyrene insulation) sheets were cut and inserted into
a plastic container filled with water (Figure 4.4). Each foam insert (of 19 mm slice
thickness) had small holes placed randomly throughout, allowing for the water to pass
through. These material selections were made based on the variation between the
density of each material (Styrofoam minimum density 0.02 g/cm3; water 1 g/cm3).
The varying densities would see varying attenuation of each material on CT, giving
different intensities in the image between the two materials. For visualisation on MRI,
the Styrofoam structure does not contain loosely bound hydrogen and therefore would
provide a negligible signal when imaging water.
4. Styrofoam and vitamin E capsules
Six sheets of the aforementioned Styrofoam were milled into a shape designed to fill
the bore of the scanner with maximum dimensions of 350 mm in height and 550 mm
in width (Figure 4.5). The sheets were assembled together, giving the prototype a
4.2. Prototype Development 50
Figure 4.4: Schematic of the Styrofoam-water prototype. The blue represents the layers of
foam, with the holes throughout. The rest of the container was filled with water.
Figure 4.5: Foam-vitamin E prototype. Holes were systematically drilled in a grid pattern
throughout the foam with the holes filled with vitamin E capsules.
length of 150 mm. Each slice contained holes drilled in a systematic grid pattern,
defined in Cartesian coordinates. Each hole was approximately 8 mm in diameter to
enable the insertion of Vitamin E capsules (19 mm length, 8 mm diameter) within
each. The capsules were the source of signal for the MR images. Alternating foam
layers had an offset grid pattern so each capsule could be distinguished between the
layers and providing a means for determining through plane distortion, rather than
only investigating the distortion in an axial plane.
5. Styrofoam and MRI markers
A small scale prototype following the previous design was developed to test specific
MRI markers as opposed to vitamin E capsules as the phantoms grid points. Each
foam layer was milled into a baseless circular shape with a height of 160 mm and a
width of 130 mm. Four layers of foam were assembled together, giving a length of
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Figure 4.6: Styrofoam-marker prototype. The Styrofoam housing structure with small holes
systematically drilled within to form two offset grid patterns. Two markers are shown placed
in the phantom (yellow)
76 mm. Small indentations were systematically placed on each foam sheet to allow
for the placement of Beekley PinPoint MRI markers (Figure 4.6). These commercial
markers consisted of Radiance R© liquid contained within a 6 mm plastic diameter. The
offset grid pattern was included in this prototype.
6. Uniboard and MRI markers
The next prototype saw the Styrofoam from the previous design replaced by layers of
flat sheet panel polyethylene and polypropylene (Dotmar Uniboard Eco) (Figure 4.7).
This material is marketed for construction purposes as a timber replacement material.
It consisted of a combination of high density polyethylene and polypropylene to give
a rigid structure whilst still maintaining a lighter weight than the same volume of
liquid with a specific gravity of 0.7 g/cm3. The phantom shape, offset grid pattern and
placement of MRI makers was the same as the previous prototype. The thickness of
this material was 15 mm, giving the prototype a length of 60 mm.
4.2.3 Prototype Performance
Table 4.2 summarises each prototypes performance in terms of the assessment criteria for
a suitable phantom design. Most prototypes were initially built on a small scale to assess
the feasibility. If it was determined that they did not meet some of the criteria and would
therefore not be a feasible solution, then the design was not pursued any further (indicated
in the table as Not assessed). For some prototypes, a larger size could have been feasible but
4.2. Prototype Development 52
Figure 4.7: Uniboard-marker prototype. The Uniboard housing structure with the holes
systematically drilled to form the offset grid pattern between layers within which the yellow
MRI markers are placed.
Table 4.2: Comparison of the acceptance criteria performance for each prototype.
Prototype MRI compatible? 3D grid? Practical? Large FOV? Visible?
CIRS 3 3 7 7 Gd3† Other7†
Lego 3 3 7 Not assessed Not assessed
S’foam/Water 3 3 7 Not assessed 3
S’foam/capsule 3 3 3* 3 3 †
S’foam/marker 3 3 3* Possible Not assessed
Uniboard/marker 3 3 3 Possible 3 †
S’foam = styrofoam
* Limited long term use
†MRI required additional signal source (saline bags or additional phantoms)
was not specifically tested in that prototype having already been determined as possible in a
previous design (indicated in the table as Possible). Since the development was for an MRI
compatible phantom, all prototypes met this criterion with all design ideas excluding the
use of any ferromagnetic materials. All MRI scans performed were acquired on 3T Siemens
MRI systems. To reduce the effects of susceptibility artefacts, the pixel bandwidth was set
to 440 Hz/pixel.
1. Anthropomorphic phantom
The cylindrical dosimeter holes allowed for placement of the signal materials when
the plugs were removed. However due to the grid pattern of the plugs, the same plug
in 2 adjacent layers could not both be filled and still maintain the desired 3D grid point
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Figure 4.8: Anthropomorphic phantom with selected dosimeter holes. Note the saline bags
beside the phantom to produce enough signal for the MRI scanner to pick up.
structure. This limits the number of points available for use.
Filling such small, open ended volumes with the tested materials was not a practical
solution. The gadolinium solution, while contained within straws and visible on MRI
(with an additional signal source - see Figure 4.8), was not an ideal solution for use
throughout the entire thorax region. To do this effectively, the straws needed to extend
through multiple layers of the thorax and therefore this would inhibit the 3D grid
structure in the z-direction (through the length of the scanner). For gadolinium, lard,
gelatine and radiotherapy bolus material, air bubbles were present within each hole.
Getting the materials in and out of the plug holes was a time consuming process.
Because the phantom was for clinical dosimetry measurements it would need to be
pulled apart after every MRI measurement and all of the signal producing materials
removed.
The whole thorax region and breast inserts were small in size meaning that the FOV
would not adequately be covered. The thorax region (without breast inserts) had di-
mensions of 20 x 25 cm (with variable length depending on the amount of phantom
slices investigated). This does not cover a large enough volume required for full FOV
distortion assessment for RTP.
CT images of the phantom revealed that the materials were difficult to differentiate be-
tween the phantom itself and therefore not providing a great gold standard to compare
the grid point locations to. On MRI, the limited amount of material being tested in the
prototype meant that additional signal was required to image the phantom (in the form
of saline bags or additional MRI phantoms). Whilst the gadolinium solution showed
up on both T1 and T2 weighted images, the lard, gelatine and bolus and wax did not.
By the time this prototype was imaged on MRI the lard, gelatine and bolus had dried
out, again reducing the amount of signal coming from each grid point location. The
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molecular structure of the wax candles used was not useful for MR imaging.
2. Lego R©
The cavities under the Lego R© blocks provided a 3D grid pattern. However, as with
the anthropomorphic prototype, filling these cavities with the lard, gelatine and bolus
materials was not a practical solution. Air bubbles were present in each cavity after
each material had been inserted. Creating a larger grid structure out of the blocks
and immersing in a liquid would still give air bubbles on the surface of the blocks
and additionally, would be difficult to contain over the volume that was trying to be
achieved. For this reason this prototype was only investigated on a small scale.
CT images of the blocks showed the 3D grid points well, since comparing against
surrounding air. The same signal issues with the materials investigated in the anthro-
pomorphic phantom would have been present when imaging this prototype and hence
MR imaging was not performed. With a more efficient way of removing air bubbles,
Lego R© may be a effective alternative. However, the weight would still be significant
if filling a Lego R© based structure with liquid or fill options over a large volume.
3. Water and Styrofoam
The water filled holes in the Styrofoam enabled a good 3D grid pattern, able to deter-
mine the point location in an axial plane (x and y) and knowing its position along the
length of the scanner (z) by the position of each foam board (Figure 4.9). This was
nicely visualised on MRI. However, due to the continuous flow of water from one side
of the board to the other through the hole, the grid was not ideal for assessing through
plane distortion.
The difference in density between the foam and water saw the foam float on top of
the water unless secured to the sides of the container and the lid weighted down.
The water phantom used to weigh down the lid also provided additional signal which
enabled a prescan to be performed (for this and other prototypes where the signal
volume was small). For a large FOV phantom following on from this design, the
weight and containment of the liquid that would be required would be impractical for
transportation and routine clinical distortion testing.
4. Styrofoam and vitamin E capsules
The aim of this prototype was to overcome some of the issues observed in the previ-
ous design. Assembling the layers of Styrofoam and inserting the vitamin E capsules
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Figure 4.9: An MRI of the water and Styrofoam prototype. The holes in the Styrofoam can
be clearly defined. Note the additional phantom placed on top on the prototype to enable
enough signal for image acquisition.
within each layer meant each grid point was completely localised in all 3 imaging
planes. The capsules were clearly visible in both CT and MR images (Figure 4.10).
In the CT, the foam had minimal x-ray attenuation which allowed for the higher at-
tenuating capsules to be well defined. The Styrofoam was not observable on the MR
images and a comparison of the grid point locations between the 2 modalities could
easily be made.
The lightweight material meant that the prototype could be easily designed on a larger
scale, with the consideration of weight being reduced, particularly when compared
to liquid filled phantoms. The prototype dimensions showed the required FOV was
achievable in the axial plane, with the potential to increase the phantoms length (cov-
erage in the z plane). The offset grid pattern was successful in distinguishing between
capsules in adjacent layers whilst still making good use of the space available. While
the capsules were large in length, this gave enough signal to be able to image that
phantom. Also, since analysis would be undertaken looking at shifts in the overall
structure of each capsule, the length was not found to inhibit the quantification of
geometric distortions.
On making this larger sized prototype, it was determined that the Styrofoam was not
an ideal long term solution. Concern was raised over its suitability as a geometrical
test object, owing to the damage and deformation of the Styrofoam that resulted over
a short period of time. Additionally, whilst the phantom was large, the number of
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Figure 4.10: Axial images of the Styrofoam water phantom prototype on CT (left) and MRI
(right).
capsules used for this prototype was small and additional signal was required in order
to image the phantom. Since this was still a prototype design, the number of capsules
would be increased and the spacing between them decreased in order to obtain greater
signal and eliminate the need for an additional signal source during imaging.
5. Styrofoam and MRI markers
This prototype was investigated at the same time as the following one. The capsules
were found not to be a suitable option for large scale 3D distortion measurement (see
below).
6. Uniboard and MRI markers
The Uniboard housing provided a more rigid phantom structure that was deemed as
more appropriate for long term use and any required transportation.
The MRI markers were found not to be as effective at providing the 3D grid point
signal. Each marker had a considerably large air bubble when compared to the overall
marker volume which was clearly visible on both CT and MR images. The air bubbles
would increase the susceptibility artifacts from the phantom itself and reduced the
amount of signal available. The vitamin E capsules have a cylindrical shape which is
better for minimising susceptibility effects [112].
From this prototype it was determined that the Uniboard structure with the vitamin E
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capsules provided the best fit to the assessment criteria and this was developed further
for the construction of the final phantom.
4.3 Final Phantom Design
4.3.1 Design features
The final phantom (Figure 4.11) consisted of layers of flat sheet panel polyethylene and
polypropylene (Dotmar Uniboard Eco) as the housing material. Vitamin E capsules were
inserted throughout to provide the MRI signal. The phantom was cylindrical in shape with
a flat bottom for stability giving a diameter of 500 mm and height of 375 mm. The length of
the phantom was 513 mm, exceeding the limits of the standard imaging capabilities of the
MRI scanner utilised, quoted as z = 450 mm.
Each Uniboard layer had a thickness of 19 mm. A total of 27 layers were used, 14 each
layer containing 227 capsules and 13 layers each containing 204 capsules. This resulted in
a total of 5830 capsules inserted into the phantom. Holes 8 mm in diameter were drilled
through each layer to ensure tight fit of the vitamin E capsules to reduce any air gaps.
The cylindrical capsule shape (diameter 8 mm; length 19 mm) was chosen to minimise
susceptibility effects from the capsules themselves [112]. Each alternating layer had these
holes drilled in an offset grid pattern (Figure 4.12), with this grid pattern being defined in
polar coordinates. Polar coordinates were used to get the maximum number of grid points as
possible within the phantom, following the circular nature of the phantom. This offset grid
position enabled observation of through plane distortions (which would not be as achievable
with capsules positioned back to back or with a rod structured phantom). In the central
phantom compartment, 2 axially centralised capsules were removed from the phantom in
order to enable localisation of the central phantom region within the acquired images.
The phantom material had a density of 0.7 g/cm3 to reduce the overall weight, with the total
phantom weight approximately 60 kg which, whilst is heavy, is lighter than a water based
phantom of the same size would be. A base constructed of the same material (external
dimensions of 800 mm x 500 mm) enabled steady transfer of the phantom between CT and
MRI. A central section of the base tray (dimensions of 513 mm x 445 mm, corresponding
to the phantom base) was pitted, leaving a thickness of 9 mm. Within this, the phantom
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Figure 4.11: Photograph of the distortion phantom positioned in a 70 cm wide bore 3 T
Siemens Skyra.
Figure 4.12: Alternating layers in the phantom. Note the offset grid pattern between each
layer for 3D point localisation. This ensures distorted points don’t overlap with capsules in
adjacent layers, aiding in through plane distortion assessment.
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body was placed and the base section held together rigidly. Ten plugs made from the same
Uniboard material with length of 19 mm and a diameter of 5 mm were positioned between
every layer to aid in holding the phantom together.
The layered structure of the phantom meant that transportation of the phantom to different
centres is achievable. The layers also allow the removal or replacement of capsules, as
may be required for analysis purposes and allows for different volumes of interest to be
investigated by imaging a reduced number of layers.
4.3.2 Criteria testing
The assessment criteria were investigated after the construction of the final phantom. The
design and manufacturing process ensured that there was no ferromagnetic materials within
the phantom, ensuring the phantom would be safe for use in a strong magnetic field and
additionally there would be no artifacts due to the presence of small traces of such materials.
From a practical perspective, the phantoms tray and handles made transportation of the
phantom achievable. The insertion of enclosed vitamin E capsules within the holes in the
housing structure provided a nice clean way of obtaining the 3D grid points and without
needing to contain a large body of water.
Imaging the phantom on both CT and MRI assessed the visualisation of 3D grid points, large
FOV and the internal phantom structure on each modality. Since MR images are subject to
distortion, a geometric "gold standard" of the phantom was required to determine the exact
location of each grid point. Hence, as was done in Chapter 3, a CT scan of the phantom
was obtained, providing a reference location for each capsule within the phantom that could
then be compared to the MR images acquired.
Figure 4.13 shows axial images of the internal structure of the same section of the phantom
as viewed on CT and MRI. The capsule locations are clearly defined, with enough intensity
contrast between the capsules and the housing materials. This can be improved by thresh-
olding the images to remove noise. Figure 4.14 shows 3D reconstructions of the phantom
as visualised on both imaging modalities. Particularly in the MR image, it can be seen that
the grid points are well defined in 3D space.
When assessing MRI distortion with phantom based measurements, the location of each in-
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Figure 4.13: Axial images of the phantom on CT (left) and MRI (right).
Figure 4.14: Rendered 3D volumes of the phantom visualised on CT (left) and MRI (right)
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Figure 4.15: Centroid locations of each capsule at the centre of the phantom as determined
by MATLAB for a thresholded CT (left) and a MR image (right).
dividual grid point must be determined on both imaging modality and compared to quantify
the distortion. For initial testing, code was developed in MATLAB to determine the cen-
troid position of each capsule within an axial plane. Figure 4.15 shows the result, with the
calculated centroid locations overlaid on the corresponding CT and MR images.
The largest axial FOV possible on the Siemens 3 T Skyra closed bore MRI scanner (500
mm x 500 mm) was used to scan the phantom (Figures 4.13 and 4.15), highlighting the
full FOV coverage of the phantom in this imaging plane. The phantom coverage through
the length of the scanner (z) is highlighted in Figure 4.16, with the phantom extending
beyond the standard imaging capabilities of the scanner. The image on the left shows the
true position of each capsule as visualised on CT at a distance of 155 mm from phantom
centre. The image on the right shows how the same section of the phantom is visualised
on MRI when the phantom centre is set up at isocentre for image acquisition. Many closed
bore scanners are quoted as having a FOV of 40-50 cm in all imaging planes for diagnostic
purposes. The dimensions of this phantom are large enough to encompass this region for
static MRI acquisition. Figure 4.16 highlights that the phantom is long enough to visualise
regions within the scanner where distortions become so severe that the geometric integrity
is severely compromised.
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Figure 4.16: Phantom a) axial slice on CT, b) axial slice on MRI at -155 mm from the centre
of the phantom, c) coronal slice on MRI and, d) sagittal slice on MRI.
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4.3.3 Design limitations
The phantom was designed specifically for distortion assessment of a Siemens 3 T Skyra
with a wide bore of 70 cm. Due to its size, it could potentially not fit into smaller bore
systems. If the phantom did fit within a 60 cm bore scanner, imaging would be limited to
acquisition using only the integrated body coil as there would not be adequate space to place
surface coils over the top. The shape was also designed specifically for the scanner. This
phantom design therefore may also not fit into other scanner configurations such as open
bore systems where there could be greater restrictions for the vertical dimensions.
The structure of the housing material created some practical issues in the analysis process.
While the overall material has a density of 0.7 g/cm3, the density changes throughout the
thickness of the board (Figure 4.17). The outer edges of the board is more compact, provid-
ing a strong exterior. The inner core is more foam in structure, designed to reduce the overall
weight. While this variation is beneficial for structure and weight considerations, it creates
an issue when imaging with CT. Figure 4.18 shows how this density variation manifests in
the CT images. In the central region of each layer (indicated in yellow), the attenuation vari-
ation between the capsules and the housing material vary enough for the capsule locations
to be properly distinguished. The edges of each layer (indicated in red) show that the higher
density region results in increased beam attenuation, similar to that of the capsules resulting
in difficulties accurately defining each capsule location. Figure 4.19 shows how this cor-
relates to CT numbers in Hounsfield units (HU), as measured on the acquired CT images
in the Pinnacle treatment planning system. For the purposes of analysis these high density
regions, as visualised on CT were masked out of the image by way of image thresholding,
to ensure that the capsule locations could be accurately determined. Since the material does
not show on MRI, this density variation does not have any visual effect here.
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Figure 4.17: The internal structure of the Uniboard material.
Figure 4.18: Density variation through the Uniboard layers visualised on CT. Top: sagit-
tal CT of the phantom. Bottom: axial image of the phantom corresponding to the mid-
dle(yellow) and edge (red) of each layer.
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Figure 4.19: Average CT numbers across the thickness of the Uniboard layers.
4.4 Conclusion
The novel phantom developed permits mapping of MRI geometrical accuracy across the
full imaging FOV as required for RTP. The axial size of the phantom encompasses the
size of patients undergoing MR scanning, whilst still allowing for the placement of surface
coils over the phantom. The length makes it suitable for imaging over various scan lengths
without the need for physical relocation and re-scanning. This phantom allowed for full 3D
quantification of a radiotherapy based MRI scanner (Chapter 5), with these measurements
then utilised in determining the dosimetric impact of geometric distortions for whole breast
radiotherapy (Chapter 6).
Chapter 5
3D distortion quantification for a
dedicated radiotherapy MRI scanner
5.1 Introduction
The RTP process requires accurate patient geometry. It is fundamental for ensuring the
dose planned is delivered to the tumour region whilst limiting dose to organs at risk (OAR).
With an increase in the use of MRI for RTP purposes [96], assessing geometric accuracy is
important, particularly when considering the potential for MRI-only planning.
System related geometric distortions in MRI are created by non-uniformity of the main
magnetic field (B0) and nonlinearities in the gradient fields. Distortions in MR images have
decreased in magnitude with improvements in technology. Most modern scanners allow
for shimming and on or off line application of vendor correction algorithms to decrease
the gradient nonlinearity and some B0 field inhomogeneity effects. While vendor supplied
correction algorithms provide a reduction, residual distortions still remain in various regions
of the scanner [Chapter 3] [38, 39].
Clinical MRI scanner performance is optimised around the isocentre of the scanner, with
gradient linearity and B0 field homogeneity decreasing with increased distance from isocen-
tre. Distortion magnitude therefore increases radially outwards, even with the application
1Part of this chapter has been published:
Walker A, Liney G, Holloway L, Dowling J, Rivest-Henault D, Metcalfe P. Continuous table acquisition
MRI for radiotherapy treatment planning: distortion assessment with a new extended 3D volumetric phantom.
Medical Physics 2015; 42(2):1982-1991
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of correction algorithms [Chapter 3]. Improvements in scanner and coil technology has
resulted in the ability to image anatomy in regions at larger distances from isocentre than
previously achievable, where distortion considerations become more imperative. The max-
imum diagnostic imaging field of view (FOV) is typically 40-50 cm in all imaging planes.
For RTP, the loss in geometric accuracy with increasing distance from isocentre is likely
to considerably reduce the maximum FOV. Geometric accuracy of within 2 mm is required
for RTP imaging and treatment QA [54], with MRI distortions greater than this requiring
consideration.
When utilising MRI for RTP, the required imaged anatomy depends on its application,
whether acquired for use in conjunction with CT or for the purposes of MR-only planning.
In some cases, registering MRI to CT may warrant smaller FOV coverage (e.g. prostate).
In such cases images may only need to encompass the anatomy of interest for contouring
and registration purposes. Other treatments (such as head and neck) may require a longer
FOV which covers a large longitudinal extent of target and avoidance tissues. If consider-
ing MR-only planning, a larger axial FOV coverage would be required to ensure the patient
skin surface is included for the required dosimetric calculations. For the purposes of RTP,
the geometrical accuracy requirement over the scan length (x, y and z coverage) is more
stringent than that required for routine diagnostic imaging. Spatial distortion assessment is
a vital part of MRI quality assurance (QA) for RTP in addition to other specific QA required
for RTP (e.g. surface coil intensity correction [68], laser alignment).
Modern clinical MRI scanners have moved towards wider and shorter bore designs to im-
prove patient comfort. Magnetic field strength may also be increased from 1.5 T to 3.0 T,
allowing faster imaging with improved imaging quality [3]. These features can make the op-
timisation of scanners more challenging, consequently increasing the geometric distortions.
More scanners have moved away from spherically optimised to cylindrically optimised mag-
nets to account for these features and to ensure the optimisation is more suited to the shape
of the patients. All of these scanner designs have characteristic uniformity and linearity
distortions. The AAPM report 100 for MR QA [43] recommends the geometric accuracy of
clinical MRI scanners should be determined. A number of studies have investigated this on
MRI scanners for the purposes of RTP [39, 49, 103, 104]. Comprehensive distortion map-
ping of each system is recommended to determine the tolerances and constraints to minimise
MRI distortion impact for RTP or provide data for a correction scheme where appropriate.
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On short bore systems, image acquisition with a moving table is one approach to increase
the scan length in the z direction. This allows images to be acquired close to the scanner
isocentre, where B0 and gradient performance is optimised. Potentially, this could reduce
the severe distortion effects at the edge of scans and improve the usable imaging range
superiorly and inferiorly for RTP. Images can be acquired close to the isocentre at different
table positions over a limited scan stitched together [113, 114]. A more recent approach
involved image acquisition with the table moving continuously through the scanner at a
constant velocity (sliding multislice (SMS)) [115–117]. Moving-table acquisitions have
been investigated in detail in magnetic resonance angiography (MRA) and whole body MRI
[116, 117], as well as for screening and staging in oncology [113, 118]. Investigations into
its utilisation in radiotherapy is limited [114]. While the SMS technique can reduce the
magnitude of distortions present in an image for a larger scan length, it does not completely
remove distortions. The technique is designed to reduce the distortion components from
the z axis with no additional benefit in the axial plane. One angiography study using SMS
[119] demonstrated additional distortion effects and blurring in all 3 imaging planes when
utilising this acquisition technique.
In this chapter, the developed 3D-phantom in Chapter 4 was utilised to quantify the geo-
metric distortions on a dedicated MRI-simulator. Investigations were made to assess the
performance of a moving table image acquisition option to determine potential benefit of
this technique for RTP. Comparisons were made to conventional static table 2D and 3D im-
age acquisition sequences. A sound understanding of the geometrical limitations for static
and moving table acquisitions is essential for investigations into MRI acquisition techniques
for utilisation in RTP. This chapter investigates the distortions from systematic factors and
the variation in these with different acquisition techniques. Other distortion considerations
including patient effects (susceptibility and chemical shift) on distortion as well as the im-
pact of geometric distortion on inhomogeneity in MR images are presented elsewhere in the
literature 2, 11, 29-31.
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5.2 Method
5.2.1 Phantom
The phantom designed and built in Chapter 4 was used to measure distortions as required
for this section of work. To validate the geometry and determine the location of the capsules
within the phantom, a CT image provided the baseline geometric ’gold standard’. The phan-
tom was scanned on an 85 cm bore, Brilliance CT big bore oncology CT scanner (Philips
Healthcare). All CT images were acquired with a FOV of 500 mm x 500 mm (512 x 512
image resolution) with a scan length greater than 514 mm to ensure the whole phantom vol-
ume was imaged. Scans were acquired with a slice thickness of 1 mm so that the CT images
could be used as a reference to analyse MR images of any slice thickness larger than 1 mm.
5.2.2 Phantom MRI scanning
MRI scans of the phantom were performed on a Siemens 70 cm bore Magnetom Skyra 3.0
T (Siemens Healthcare) (Figure 4.11). The manufacturer quotes the gradient linearity as an
average deviation equal to 0.2, 0.3, 0.2 % (x, y, z %) over 30 cm and 0.4, 0.5, 0.3 % over 50
cm. The magnet is cylindrically optimised, designed to achieve a homogeneous volume 1.5
times that of an ellipsoid system. Guaranteed homogeneity of the magnet over a 50 cm x 50
cm x 45 cm is quoted as less than 4 parts per million (ppm). All scans performed underwent
standard tune-up B0 shimming localised to the imaging volume. For this study, 3 different
acquisition methods were investigated:
1. Standard 2D image acquisition
2. 3D volume image acquisition
3. Continuously moving table acquisition: Total Imaging Matrix, Continuous Table (TimCT)
For each image acquisition sequence, 2 images of the phantom were obtained. The fre-
quency encode directions between these 2 datasets were rotated by 180o to enable separa-
tion of B0 and gradient distortion components during the image analysis process [51, 65]. A
bandwidth of at least 440 Hz/pixel was implemented for each sequence as would be used for
RT planning protocols [3] to minimise susceptibility and chemical shift. Vendor 2D or 3D
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Table 5.1: Acquisition parameters of standard imaging sequences.
Sequence
Slice thickness
(mm)
TE/TR
(ms)
Scan length
(mm)
Pixel BW
(Hz/pix)
Resolution
(pixels)
SE 2 12/2760 252 445 320 x 320
SE 3 12/2760 368 445 320 x 320
CISS 2 3.15/6.84 353 460 320 x 320
correction algorithms were applied during image acquisition as available. Scanner gradient
nonlinearities are stored in the system as spherical harmonic coefficients, enabling the gra-
dient field to be derived at any location within the magnet. The coefficients are used to cal-
culate the ideal gradient values for the scanner which are then applied to correct each voxel
position and signal intensity accordingly throughout the imaged volume. The 2D correction
provides only an in-plane correction to the distortion while the 3D correction accounts for
through-plane distortion as well. These correction algorithms provide reproducible results
within 0.5 mm. Distortions were reported at the centre of each capsule as visualised on each
slice within each dataset. Based on acceptance criteria for RTP imaging and treatment QA
[54], distortion values larger than 2 mm were considered to be significant.
5.2.3 2D and 3D acquisition sequences
The imaging parameters for the static 2D and 3D image acquisitions are outlined in table
5.1. For the 2D image acquisition, a standard spin echo (SE) sequence was used. A steady
state gradient echo sequence (CISS - constructive interface in steady state) provided the best
image quality for the 3D acquisition of the phantom and was consequently investigated. The
maximum scan lengths achievable for the given slice thickness and coil capabilities for each
sequence was acquired. The phantom centre was aligned to the scanner isocentre. For these
scans 2D correction was available as part of the imaging protocol whereas 3D correction
was performed retrospectively on the scanner console.
5.2.4 TimCT - extended FOV
The phantom was placed on the scanner and covered with two 18 channel body coils for
imaging the whole phantom volume with TimCT. The table was then moved into the scanner
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Table 5.2: Acquisition parameters of the TimCT sequence and the corresponding sequence
without the TimCT option utilised.
Sequence
TE/TR
(ms)
Scan length
(mm)
Pixel BW
(Hz/pix)
Resolution
(pixels)
Table speed
(mm/s)
Slab length
(mm)
Spoiled GRE
(TimCT)
1.47/190 540.3 610 512 x 512 1.1 60
Spoiled GRE
(TimCT)
1.47/190 550.5 610 512 x 512 2 110
Spoiled GRE
(Non TimCT)
1.47/452 365 610 512 x 512 0 365
so that one end of the phantom was located at the scanner isocentre and the whole phantom
could then be moved through the bore. All images were T1 in-phase Dixon spoiled GRE
sequences acquired with 5 mm slice thickness. Table 2 shows the imaging parameters for
different table speeds. The slab length refers to the scan length being imaged as the table
moved and was dependent on the table speed selected. After images were acquired with
the TimCT option selected, the phantom was setup with the phantom centre aligned to the
scanner isocentre. The same sequence was then acquired with static table acquisition for
comparison. These scans were all acquired with the vendor 3D correction algorithm applied.
5.2.5 Distortion assessment
5.2.5.1 Image registration
Three dimensional quantification of the geometric distortion was obtained by rigid and de-
formable registration between the CT and MR images. Two programs were required for the
registration process:
• MILXView is a 3D medical imaging tool developed by the Australian E-health Re-
search Centre with the Commonwealth Scientific and Industrial Research Organisa-
tion define CSIRO allowing the visualisation and processing of 3D medical images.
• NiftyReg is an open-source software tool enabling the implementation of non-rigid
and deformable registration between images. Version 1.3.9 of this software was
utilised for this work.
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A robust inverse-consistent registration algorithm was used to rigidly align the CT and MR
images within MILXView [120]. The algorithm handled the position and orientation infor-
mation contained in the image header and provided a fully automatic result. All MR images
acquired were rigidly registered to the CT with 1 mm slice thickness, ensuring all datasets
were in the same frame of reference. The MR images then matched the 0.98 x 0.98 x 1
mm voxel resolution of the CT dataset. Performance of the rigid registration was visually
assessed before continuing. After rigid registration, each resulting MRI dataset was non-
rigidly registered to the CT dataset. The deformable registration method was based on a
cubic B-spline free-deformation model using a normalised mutual information metric from
the non-commercial open source software (NiftyReg version 1.3.9) [121]. The registration
was performed in 4 iterations with final grid spacing of 25 mm. In this implementation, all
control points were optimised and interpolation performed in 3D across the whole image at
each step. The accuracy of the registration algorithm was within half a pixel (MRI pixels:
1.6 mm x 1.6 mm).
MATLAB code was written to determine the centroid position of each vitamin E capsules
on each CT slice. Distortion information was pulled out of the deformation fields obtained
corresponding to these points so the distortion values were reported at the centroid position
of each capsule. In doing this, the distortion was reported in regions where there is informa-
tion provided by signals in both the CT and MR images and not in between capsules where
distortion values are interpolated in regions of no signal.
5.2.5.2 Gradient and B0 distortion components
Non-rigid image registration resulted in the determination of the total geometric distortion
(dist_total). Following a previously reported method [51, 65] image acquisition was re-
peated with the frequency encode direction reversed. The frequency encoding direction (y)
is subject to geometric errors from both B0 inhomogenity and gradient nonlinearity whilst
the phase encoding direction (x) is only subject to distortions from gradient nonlinearities:
y1 = y +
∆B0(x, y, z)
Gy
+
∆BGy(x, y, z)
Gy
(5.1)
x1 = x+
∆BGx(x, y, z)
Gx
(5.2)
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Figure 5.1: Phantom images a) CT, b) MRI with anterior (ant)-posterior (post) frequency
direction and, c) subtraction of two MR images with frequency encode direction reversed.
where y1 and x1 are the distorted locations, y and x are the true position, ∆B0 is the distor-
tion contribution from B0 inhomogeneity, Gy is the frequency encoding strength, Gx is the
phase encoding strength ∆BGy is the distortion contributions from gradient nonlinearities
in the frequency encoding direction and ∆BGx is the distortion contributions from gradient
nonlinearities in the phase encoding direction. Analysis on images with reversed frequency
encoding directions can separate these components. In reversing the gradients the direc-
tion of the ∆BGy term in equation 5.1 is reversed. Substituting the resulting equation into
equation 5.1 gives:
y1 = y +
∆BGy(x, y, z)
Gy
(5.3)
Hence the difference in images of reversed frequency encode direction allows for the deter-
mination of the B0 inhomogeneity effects.
In this study, a deformation field was obtained by registering the MR images of opposing
frequency encode directions. The result was halved to give the component distortion due
to B0 inhomogeneity (dist_B0) since the true position of objects lies halfway between its
location in each image [65]. The B0 distortion component was then subtracted from the
total deformation field obtained in the MR-CT registration, giving the residual distortions
due to the gradient nonlinearities (dist_Grad) (Figure 5.1). Subtraction of deformation fields
was conducted using a Simple Medical Imaging Library Interface SMILI program.
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Figure 5.2: Vector maps indicating regions of distortion ≥ 2 mm for the a) dist_Grad and b)
dist_B0 components of distortion for the standard 2D SE acquisition sequence with 2 mm
slice thickness with the 3D correction algorithm applied.
5.3 Results
5.3.1 Standard static acquisition sequences
Distortions due to residual gradient nonlinearities and B0 inhomogeneities are separated in
Figure 5.2 for the standard SE sequence acquired with 2 mm slice thickness (3D correction
algorithm applied). The vector fields are thresholded to highlight regions within the imaging
FOV where distortions were greater than 2 mm. The vectors indicate the total distortion in
all directions (x, y and z). Distortions resulting from residual gradient nonlinearities are
greater than those due to the B0 inhomogeneity. The dist_Grad were greatest at the superior
and inferior regions of the image with dist_B0 largest at the extreme regions of the axial
FOV.
Table 5.3 indicates the overall geometric performance of each sequence (dist_total), ac-
counting for variations in scan length due to sequence capabilities. The table includes re-
sults for 2D and 3D corrected images, the percentage of the phantom length scanned and
differences in the image length acquired per second, based on the acquisition time of each
sequence. Images with the retrospective 3D correction applied had an improved geometrical
performance.
Figure 5.3 shows the variations in the frequency distribution of distortion magnitude across
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the 3 sequences acquired, with 2D vendor correction algorithm applied compared to when
the 3D correction algorithm is selected. Table 5.4 breaks down the mean, median and max-
imum distortion values for each scan.
The convergence region of the registration algorithm is defined as the region where the
accuracy of the registration algorithm is better than 1 pixel. This region was found to be
within a length of ± 119 mm and an axial radial distance of r = 180 mm from the centre
of the scanner. The magnitude of distortion was accurately measured within this region,
even when the spatial displacement greatly exceeded the 2 mm tolerance limit. Beyond this
volume, extreme distortion resulted in some capsules no longer being visible in the image.
As such, distortion measurements beyond this region could not be reliably measured but can
be assumed to be much greater than 2 mm. Black rings began appearing beyond this point in
the images with the 3D correction algorithm applied in regions of severe distortion or where
capsules were not observable in the 2D corrected images.
5.3.2 TimCT
Vector field maps for the total distortion observed for the spoiled GRE sequence acquired
with a static table and TimCT with table speeds of 1.1 mm/s and 2 mm/s are shown in Figure
5.4. The longer scan length imaged with TimCT is evident when compared to the static
table acquisition. Distortion patterns for TimCT scans were more consistent through the
phantom volume compared to the static table where a large reduction in geometric integrity
was observed at the edge of the field where the through plane distortion was worse.
Table 5.5 highlights the mean, median and maximum distortion values (dist_total) for the
different couch speed acquisitions. Figure 5.5 shows the variations in the frequency distri-
bution of distortion magnitude across the 3 acquisition speeds.
Figure 5.7 shows the percentage of points within a defined phantom volume where distor-
tions were observed to be greater than 2 mm for the static table, TimCT 1.1 mm/s and TimCT
2 mm/s scans on the left, and the 2 mm SE, 3 mm SE and 3D CISS on the right. The vol-
umes were defined from the centre of the phantom, with varying through plane lengths (±
z) and radial distances in the axial plane (r) (Figure 5.6). All measurements were reported
with respect to the phantom centre as opposed to scanner isocentre since this provided a
consistent reference point for static and moving table acquisitions. The maximum distortion
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Figure 5.3: Comparison of the frequency distribution of distortion when applying the vendor
2D correction compared to 3D correction for the 2 mm SE (top), 3 mm SE (middle) and 2
mm CISS (bottom) acquisitions.
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Table 5.3: Geometric performance of the standard acquisition sequences.
Sequence
% phantom
imaged
Distance from
isocentre where
distortion ≥ 2 mm
% phantom with
distortion < 2 mm
Nominal acquisition
time*
(minutes : seconds)
2 mm SE 49 29:56
- 2D corrected 98 mm 29
- 3D corrected 152 mm 44
3 mm SE 72 20:22
- 2D corrected 82 mm 30
-3D corrected 154 mm 54
CISS 69 13:30
- 2D corrected 93 mm 32
- 3D corrected 148 mm 51
Spoiled GRE 71 147 mm 47 2:41
(NonTimCT)
Spoiled GRE 100 140 mm 87 9:30
(1.1 mm/s)
Spoiled GRE 100 55 mm 61 5:26
(2 mm/s)
* Nominal acquisition time = time required to image whole phantom
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Table 5.4: Distortion comparison between 2D and 3D corrected images.
Sequence Mean Median Maximum
2 mm SE
2D corrected 2.07 1.69 7.88
3D corrected 1.25 1.19 4308
3 mm SE
2D corrected 2.90 2.40 9.81
3D corrected 1.42 1.38 4.37
2 mm CISS
2D corrected 2.64 2.16 7.62
3D corrected 1.56 1.43 4.89
Table 5.5: Distortion comparison between static Vs TimCT images.
Sequence Mean Median Maximum
Spoiled GRE 0 mm/s* 1.60 1.46 6.07
Spoiled GRE 1.1 mm/s 1.33 1.23 4.42
Spoiled GRE 2 mm/s 1.78 1.65 5.80
* 71% phantom imaged
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observed is reduced when TimCT is utilised. Table 5.3 compares the spoiled GRE sequence
investigated for TimCT purposes to the standard static acquisition sequences.
Figure 5.8 compares the geometric performance of the spoiled GRE without TimCT com-
pared to TimCT with a table speed of 1.1 mm/s over different radial distances and scan
lengths from the scanner centre. It shows the volume percentage comparison in which dis-
tortions are less than 2 mm within the volume in question. Values greater than 1 indicate the
TimCT sequence performed better geometrically.
As was found for the standard static sequence acquisitions, beyond the convergence region
of a length of ± 119 mm and radial distance of r = 180 mm from the phantom centre on
the static spoiled GRE, grid points were either not visible in the image or the distortions
were too great for the registration algorithm to perform accurately beyond this point. The
registration algorithm was not found to fail for the TimCT images.
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Figure 5.4: Vector maps indicating regions where total distortion ≥ 2 mm for the spoiled
GRE sequence acquired with table speeds of a) 0 mm/s, b) 1.1 mm/s and c) 2 mm/s
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Figure 5.5: Comparison of the frequency distribution of distortion between acquiring images
at the 3 different table speeds.
Figure 5.6: Schematic defining the volume variations for distortion analysis. All measure-
ments were performed within a given distance from the centre of the phantom in the through
plane (± z) and axial (r) directions.
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Figure 5.7: Normalised percentage of points within the imaged volume at a given distance
from the centre of the phantom (± z) for a given axial radial distance from the centre of the
scanner (r) where the distortion is greater than or equal to 2 mm for the a) spoiled GRE Non
TimCT, b) spoiled GRE TimCT at 1.1 mm/s table speed, c) spoiled GRE TimCT at 2 mm/s
table speed, d) standard 2 mm SE, e) standard 3 mm SE and, f) 2 mm CISS sequences.
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Figure 5.8: Ratio of the spoiled GRE regions where distortion < 2 mm for images acquired
with TimCT at 1.1 mm/s and with a static table (TimCT/Non-TimCT). Values greater than
1 indicate the TimCT sequence performed better geometrically
5.4 Discussion
The distortion distributions observed in Figure 5.2 highlight the optimisation characteristics
of the scanner utilised. When looking at the gradient component of distortion, the distortion
magnitude is worse at the superior-inferior edges of the FOV where the gradient field lin-
earity declines due to the short bore size. The B0 field components show that this effect is
worse axially around the bore edges as opposed to the through plane edges. This highlights
the cylindrical nature of the magnet used in this new scanner and emphasises the need for
QA on each specific system. It should be noted that B0 inhomogeneity is a more crucial
component when imaging certain patient anatomy (e.g. sinuses within the head), creating
regional variations on top of the system effects described here. In clinical acquisitions ap-
propriate steps should be taken to address this including further increasing the bandwidth,
more localised volumetric shimming and even considering B0 correction. Choice of appro-
priate MRI protocols [3, 81] within a department is an important part of this process.
Comparison of the static image acquisitions in table 5.3 highlights the difference in 2D and
3D vendor correction algorithm application. During image acquisition, the SE and CISS se-
quences only permitted 2D correction application while the 3D correction could be applied
to the spoiled GRE. For the SE and CISS sequences, retrospective 3D correction could be
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performed. This highlights a practical limitation that may be encountered during imaging
as well as emphasising the importance of knowing the capabilities of each system, both
on and offline. Since the 2D correction algorithm does not consider the slice selection di-
rection, through plane distortions are not taken into account. As expected, the geometric
performance of sequences acquired with the 2D algorithm applied was poorer than the 3D
corrected images in which distortion is considered in all 3 axes. This resulted in an im-
provement of the percentage of the phantom volume where distortions were within 2 mm of
15%, 24% and 19% (absolute percentage coverage) for the 2 mm SE, 3 mm SE and CISS
sequences respectively. Distortions greater than 2 mm were not observed within a radial
distance of 148 mm from isocentre. For radiotherapy purposes, the highest order correction
algorithm available should be applied. Restrictions in scanner and sequence capabilities in
applying these corrections indicate more potential improvements could be made towards
MRI scanning options for the purposes of RTP.
The moving table option offered with TimCT acquisition provided a significant increase to
the field length that can be imaged compared to static table acquisition (table 5.3; Figures
5.4 and 5.7). The vendor quotes the TimCT option allows for imaging with field lengths of
205 cm. It was tested to 50 cm in this study which encompassed the length of the phantom
and exceeded the maximum scan length limits of static table acquisition.
Of the sequences investigated, TimCT acquisition with a table speed of 1.1 mm/s performed
the best geometrically. However this came at the cost of time. Acquisition time for the
TimCT 1.1 mm/s was 9 minutes, 30 seconds, 3.5 times greater than that of the static table
acquisition for the same spoiled GRE sequence (2 minutes, 41 seconds to image the whole
phantom). While that resulted in increased image scan length and distortion improvement at
superior and inferior regions of the image, the additional scan time could lead to increased
patient movement and associated artifacts within the image, potentially reducing its benefit
for RTP. Time variations are also subject to the desired imaging sequence. For example,
TimCT at 1.1 mm/s with the spoiled GRE resulted in an improved acquisition time when
compared to the static table SE sequences (14 minutes, 40 seconds), the latter with scan
lengths of only 47-68% that of the spoiled TimCT GRE.
However with TimCT, an additional source of error is introduced with the through plane
table movement. This is evident when comparing the 1.1 mm/s and 2 mm/s table speeds
(Figure 5.4 b, c; Figure 5.7 b, c). Through plane movement results in blurring of the capsules
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and an increase in the severity of the gradient nonlinearity distortions across all 3 imaging
planes. This effect worsens with increasing distance from the isocentre of the scanner due
to the increased gradient nonlinearities, as discussed for blood vessel imaging in MRA by
Polzin et al. [119].
Table movement amplifies the system distortions and manifests as blurring within the image.
Since these distortions are larger at the outer edges of the FOV, blurring is worse in these
regions with the effect minimal in the central FOV. With TimCT acquired at 1.1 mm/s,
blurring resulted in an increase in apparent capsule volume of 43 ± 5 % (± 2 standard
deviations) at r = 225 mm from scanner centre and 95 ± 8 % at r = 240 mm. Blurring
increased with table speed with the 2 mm/s TimCT average capsule volume increasing by
93 ± 1 % and 170 ± 5 % at r = 225 and r = 240 mm, respectively. Increasing the table
speed from 1.1 mm/s to 2 mm/s resulted in a 26% increase in the percentage of grid points
experiencing distortions greater than 2 mm. While TimCT at 2mm/s permitted a reduction
in maximum distortion and a more regular distortion pattern compared to the static table
acquisitions, it performed worst in the distance from isocentre where distortions greater than
2 mm became observable. Distortions became greater than 2 mm beyond a radial distance
of 55 mm from phantom centre. This corresponded to the maximum distance from scanner
isocentre that an image could be acquired at that speed.
Figure 5.8 indicated regions for the best geometric performance between the static and 1.1
mm/s TimCT image acquisitions. When imaging within a small radius from isocentre with
a short scan length, the two techniques perform similarly, with the Non TimCT acquisition
performing slightly better for a larger scan length. As the scan length increased beyond
± 100 mm from phantom centre, the TimCT sequence was found to perform best for all
radial distances investigated. This is dependent on the table speed. When the table speed
was increased to 2 mm/s, the static sequence performed geometrically better, though it was
not able to image the whole phantom. This information is useful when determining what
acquisition technique to use for the purposes of RTP, given the anatomy of interest, the FOV
required and the role of the MRI data. For example for centrally located anatomy, such as
brain, head & neck or when deliberately using a small FOV (e.g. prostate) to subsequently
register to CT, static acquisition may be sufficient. As indicated in Figure 5.7, if imaging
over a distance of ± 100 mm from the phantom centre, the static image and TimCT at
1 mm/s perform very similarly, with distortions greater than 2 mm increasing beyond a
radial distance of 200 mm from the scanner centre. In other instances where extended z
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coverage is warranted or anatomically suited (e.g. peripheral sites, lung etc.) then a moving
table strategy may be important. Figure 5.7 highlights the potential use of TimCT for this
purpose. At 1 mm/s, the percentage of points experiencing more than 2 mm distortion
remaining constant over the whole phantom volume, compared to the static case where the
whole volume could not be imaged and the distortion increased with increasing distance
from the phantom centre. Although TimCT is currently a vendor specific implementation,
this work has shown advantages in repositioning anatomy rather than simply extending the
image volume which should be considered on other systems using stepping table variations.
This paper served to highlight the geometrical variations that these techniques manifest and
emphasises the importance of understanding the limitations of MRI acquisitions.
TimCT scans acquired with table speeds greater than 2 mm/s were investigated. These were
not analysed however, with capsules towards the outer edge of the phantom in axial slices
becoming severely blurred and displaced. Some of these points were no longer observable
in the image and the analysis process would not have been able to account for the loss of
information. Increasing the table speed was done at the expense of the slab length imaged
as the table moved through the scanner. Faster table speeds were therefore susceptible to
additional blurring due to the movement as well as increased gradient nonlinearity effects
due to an imaging area extending further from isocentre.
One of the limitations of the study was the performance of the registration algorithm at high
distortion regions at the FOV edges in the static acquisitions. The registration performed
well in central regions of the phantom where no grid point information was lost. Outside
the convergence region of the registration algorithm, the image contrast is not sufficient and
thus the algorithm merely extrapolates the transformation. This was apparent from visual
inspection. Distortion values greater than 2 mm were assumed for regions of the phantom
that could not be imaged with static acquisitions and the regions in which the registration
algorithm failed. Because the distortion patterns were more regular throughout the whole
imaging volume for the TimCT scans and there was no field limitations resulting in a loss
of capsule visualisation, the registration algorithm was not found to fail for these images.
The ability to change imaging parameters from the default sequence setting for TimCT was
more restricted than the static spoiled GRE acquisition option. Of particular note for this
study were the slice thickness options available and the restrictions this put on table speed
options. As a result, the slice thickness of 5 mm investigated for this sequence was larger
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than the 2 mm generally used for treatment planning on CT. TimCT was also limited to 2
acquisition sequences, the spoiled GRE and a single shot turbo spin echo (TSE) sequence.
The TSE sequence was scanned during preliminary data collection however the SNR on the
phantom images was too low for the purposes of image analysis.
Static or moving table MRI acquisition for RTP would need to be assessed based on the
application. Both techniques could be useful in providing supplementary information to
planning CTs. Static images can provide the geometric information required, particularly
over anatomical regions extending over a shorter scan length. In some cases, TimCT would
be required to ensure adequate scan length coverage, particularly if dealing with long OARs
or target volumes. The same argument could be used for their application in MR-only
planning.
5.5 Conclusion
The capability of the designed phantom to be imaged over a large FOV is highlighted in
this chapter. Measurements made with both static and moving table acquisitions demon-
strated variations in the achievable geometric accuracy with each technique. The moving
table technique (TimCT) was shown to extend the distortion free volume of the phantom by
continuously acquiring data from a small section around the scanner isocentre. There are a
number of limitations to this procedure including choice of available pulse sequence and ef-
fects of increasing table speed. However, this work illustrates the nature of MRI distortions,
demonstrating geometric variations that can occur between image acquisition techniques (as
opposed to sequence variations alone) which is not well known in the RT community. It is
important to fully characterise an individual MRI system and use this knowledge to select
the most suitable imaging protocol for radiotherapy treatment planning.
Chapter 6
Distortion implications for whole breast
IMRT
6.1 Introduction
With the growing interest in the utilisation of magnetic resonance imaging (MRI) for radio-
therapy treatment planning [92, 96], the geometric distortions associated with MRI require
consideration [3]. Distortions due to nonlinearities in the gradient coils and inhomogeneities
in the B0 field increase in magnitude with increasing distance from the MRI isocentre [Chap-
ter 5]. The patient introduces additional effects such as chemical shift and susceptibility due
to the variations in magnetic properties of different tissues. Although the implementation of
vendor supplied distortion correction algorithms can reduce the system related distortions,
they are not completely removed [Chapter 3]. Several methods can be utilised to correct for
patient-specific distortions including acquiring two images with reversed gradient direction
[101] and B0 mapping [122], however clinical implementation of these can be challenging
and is not routinely implemented [3]. Acquiring images with a high imaging bandwidth
(BW) can be used to minimise the distortions due to chemical shift and magnetic suscepti-
bility. However increasing the imaging BW creates a reduction in the signal-to-noise ratio
(SNR) and increasing the BW required to remove these effects completely from the images
are detrimental to the image quality and the usefulness of the images [65].
1Part of this chapter has been submitted for publication:
Walker A, Metcalfe P, Liney G, Batumalai V, Dundas K, Glide-Hurst C, Delaney G, Boxer M, Yap ML,
Dowling J, Rivest-Henault D, Pogson E, Holloway L. MRI geometric distortion: Impact on tangential whole
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Investigations into the dosimetric impact of MRI geometric distortions on the radiotherapy
treatment planning (RTP) process have been conducted for brain and prostate patients. Brain
studies focus on a small field of view (FOV) at the centre of the scanner where distortions
are minimal [32, 97]. The prostate studies were conducted on low magnetic field strength
scanners [73, 98], or on phantom geometry [77]. Prott et al. [100] suggested that these
effects may be of major relevance to breast cancer treatment, where the anatomy extends
out into regions of higher geometrical inaccuracies.
It is estimated that 83% of breast cancer patients should undergo radiotherapy as part of
their treatment [123]. A number of techniques are available for treating breast cancer with
external beam radiotherapy. These include Three-Dimensional Conformal Radiotherapy
(3D-CRT), Intensity Modulated Radiation Therapy (IMRT) [124], hybrid methods combin-
ing 3D-CRT and IMRT techniques [125], and Intensity Modulated Arc Therapy (IMAT)
[126]. Whole breast radiotherapy sees the whole breast volume irradiated after breast con-
serving surgery. Partial Breast Irradiation (PBI) involves only the tumour or lumpectomy
cavity being irradiated, in order to spare surrounding healthy tissues.
The aim of the current study was to investigate the effect of MRI geometric distortions
on the dose distribution on tangential whole breast IMRT. The impact of residual system
distortions alone was compared for two different scanners with different field strengths and
configurations. The influence of the combined distortion arising from the system and the
patient was also investigated on the higher field strength system.
6.2 Methods
6.2.1 Phantom data
System distortion maps were obtained from two separate MRI scanners with different con-
figurations and field strengths using specific phantoms.
The novel 3D phantom developed in Chapter 4 was was scanned on a closed, wide-bore 3 T
Siemens Magnetom Skyra (Siemens Medical Systems, Erlangen, Germany). A 2D T2 spin
echo sequence (voxel size 1.56 x 1.56 x 2 mm3, 500 x 500 x 252 mm3 FOV, 445 Hz/pixel,
TE/TR/flip angle 12 ms/2760 ms/90o was used with a vendor supplied 2D correction algo-
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rithm applied. A corresponding CT of this phantom was acquired to provide the undistorted
geometry of the phantom.
For the 1.0 T Panorama high-field open vertical-bore system (Philips Medical Systems, Best,
The Netherlands), a vendor-supplied 3D distortion phantom consisting of docusate sodium
capsules within a foam structure [70] was scanned using a 3D T1 spoiled gradient echo
sequence (voxel size 0.938 x 0.938 x 2 mm3, 450 x 450 x 400 mm3 FOV, 385 Hz/pixel,
TE/TR/flip angle: 3.77/30 ms/60o, 3D correction algorithm applied). A corresponding CT
of this phantom was acquired.
6.2.1.1 Quantification of residual systematic distortions: phantom study
To quantify systematic distortions, the CT and MR phantom images from each scanner were
registered. A robust rigid registration method [120] was applied to compensate for changes
in position between modalities, then a deformable multi-scale (4 levels) B-spline registra-
tion algorithm [121] was used to account for non-linear MRI deformations. To promote
smoothness, the spacing of the final B-spline control point grid was adjusted by selecting the
largest value that would allow accurate alignment of the phantom markers post-registration,
as determined by visual assessment. We identified 25 mm and 10 mm as the best spacing pa-
rameters for the Skyra and the Panorama images, respectively. The registration results were
manually validated by verifying that the phantom markers were accurately aligned [Chapter
5].
6.2.2 Patient data
Datasets for 18 patients who underwent whole breast external beam radiotherapy (12 right
sided, 6 left sided) were obtained. Patients were positioned on both CT and MRI using the
same treatment simulation set-up on a flat table and in a head first supine position. Non-
contrast CT images were acquired on a Philips Brilliance Big Bore scanner (Philips Health
Care, Cleveland, OH) (voxel size 0.98 x 0.98 x 2 mm3, 500 x 500 mm2 FOV). The MRI
was acquired on the aforementioned 3T MRI scanner for comparison with the acquired
phantom images. A 2D T2 TSE was acquired with 2 mm slice thickness and an axial square
pixel size ranging from 0.52-0.59 mm2. The FOV ranged from 400 x400 mm2 to 450 x
450 mm2 (depending on patient size) with TE/TR/flip angle: 88 ms/5840 ms/167o. Images
were prospectively corrected using the vendor-supplied 2D gradient distortion correction
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algorithm. In order to investigate the effects of BW, patients were acquired with either a
pixel BW of 230 Hz/pixel or 450 Hz/pixel.
Clinical target volume (CTV) and seroma volumes for each patient were contoured by an
experienced radiation oncologist based on the CT images. Lung, heart, contralateral breast
and external patient volumes were contoured by an experienced senior planner.
6.2.2.1 Quantification of residual systematic and patient-induced distortions: patient
study
Distortion maps representing the combined residual systematic and patient-induced distor-
tions were estimated by registering the patient CT images with the corresponding patient
MRI (Skyra only). The registration process used for the phantoms image was also used for
the patient data, but with a final control point grid spacing of 15 mm, which was found to
give adequate accuracy at a realistic smoothness level. Each registered image was visually
assessed for accuracy, with particular focus around the breast and chest wall regions.
6.2.3 Image distortion
To investigate the impact of MRI geometric distortion, each patient CT (and the corre-
sponding contours) was distorted in 3 ways using the phantom-computed distortion maps
(Skyra and Panorama) and using the combined systematic and patient-induced distortion
maps (Skyra only) (Figure 6.1). The phantom data allowed investigations on the potential
dosimetric variations between MRI scanners of different configurations in whole breast RTP
without the added complexity of patient-induced effects. With the 3T, using both phantom
and patient based distortion maps allowed for a comparison between the system-related only
and combined system and patient-related effects.
In all cases, contour variation was assessed for CTV, seroma, contralateral breast, combined
lung and heart volumes. The Dice similarity coefficient (DSC) was obtained between origi-
nal and distorted contours to investigate their overlap (equation 6.1):
DSC = 2× intersection volume(original contour volume + distorted contour volume) (6.1)
Original and deformed contour sizes were also computed.
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Figure 6.1: Methodology schematic showing the image distortion processes and the result-
ing images.
6.2.4 Treatment planning
After registration, four different CT datasets were considered (Figure 6.1):
1. The original CT,
2. A CT dataset deformed by the Skyra residual system distortions (phantom measured),
3. A CT dataset deformed by the Panorama residual system distortions (phantom mea-
sured) and,
4. A CT dataset non-rigidly registered to the patient geometry on the Skyra.
For each of the simulated CT datasets, tangential whole breast plans were generated to a
prescription of 50 Gy in 25 fractions in accordance with standard clinical protocols. In-
verse planned IMRT plans were created using an automated script in Pinnacle Version 9.6
(Philips Radiation Oncology Systems, Milpitas, CA), which established a gantry angle and
determined field size and beam modulation. Beam angles with an isocentre located at the
centre of the Planning Target Volume (PTV) (defined as an expansion of the Clinical Target
Volume (CTV) of 1cm superior-inferior, 0.5 cm left-right and 0.5cm anterior-posterior) were
automatically determined based on the location of the lungs, PTV and contralateral breast
contours. Beam angle was manually adjusted until it was deemed to be ideal for the shape
of a particular patient. After completion of the script, each plan was individually optimised
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Table 6.1: The DVH criteria for plan evaluation (Based on RTOG guidelines and clinical
experience).
Target/OAR structure Ideal criteria Acceptable criteria
PTV > 95% receives > 47.5 Gy ≥ 95% receives ≥ 45 Gy
Maximal 1 cc ≤ 53.5 Gy Maximal 1 cc ≤ 55 Gy
Seroma > 99% receives > 47.5 Gy > 99% receives > 46 Gy
Maximal 1 cc < 55 Gy Maximal 1 cc < 57.5 Gy
Combined Lung < 10% receives 10 Gy < 10% receives 10 Gy
Mean dose < 10 Gy Mean dose < 10 Gy
Ipsilateral Lung < 15% receives > 20 Gy < 20% receives > 20 Gy
Heart Mean < 4 Gy Mean < 5 Gy
Contralateral breast Maximal 1 cc < 1.86 Gy Maximal 1 cc < 3.10 Gy
by altering the appropriate IMRT optimisation parameters to achieve clinically acceptable
Dose Volume Histogram DVH criteria [127] (table 6.1) and visual acceptance by an experi-
enced senior planner. Qualitative visual assessment was conducted to confirm homogeneity
of the dose distribution within the PTV, as well as ensuring high dose levels did not occur
outside the PTV and that the maximum dose occurred within the PTV. After final optimi-
sation, multi-leaf collimator (MLC) banks were shifted on appropriate beam control points,
so that around 80% of the dose was planned to be delivered with 2 cm anterior overshoot.
6.2.5 Dosimetric evaluation
Once plans were optimised on each distorted dataset, the beams from these plans were
exported and then imported onto the original CT image (Figure 6.2) with the beam isocentre
placed at the centre of the undistorted PTV, simulating a treatment set-up position. Monitor
units (MU), beam weights and dose grid resolution were kept consistent and recomputed on
each distorted dataset, then the dose criteria were tabulated. Each of these plans was then
assessed and given a pass or fail based on its ability to meet both DVH and visual acceptance
criteria. Plans meeting the DVH and visual assessment criteria were generated on all 18
original (undistorted) CT images. This provided a baseline from which the distortion impact
could be tested.
6.3. Results 94
Figure 6.2: Workflow for the assessment of the geometric distortion on the planning process.
Left: Plan optimised on original CT dataset; Centre: Plan optimised on distorted CT dataset;
Right: Plan optimised on distorted CT dataset copied and recomputed on the original CT
dataset.
6.3 Results
6.3.1 Scanner distortions
The maximum distortion on the Skyra was measured at 7.88 mm (mean = 2.07 mm; 95%
of volume experienced distortions below 4.67 mm) over a 500 x 500 x 254 mm3 FOV,
with distortion on the Panorama reaching 11.87 mm (mean = 1.71 mm; 95% of volume
experienced distortions below 4.56 mm) over a 475 x 380 x 420 mm3 FOV. The largest
distortions were observed at the FOV edges.
6.3.2 Contour deformation
The average size of contoured volumes is displayed in Table 6.2. The maximum distortion
observed in each contour and the DSC overlap between distorted and undistorted contours
is presented for each distortion type, averaged across all patients. Distortions observed in
the patient distorted images were larger in magnitude than from the phantom alone mea-
surements, as expected with the addition of susceptibility and chemical shift artefacts, setup
and patient movement discrepancies. Distortion vector fields displaying where distortions
≥ 2 mm are shown in Figure 6.3 for all three deformations, relative to the contour loca-
tions. Maximum distortions for the patient measurements (Figure 6.3.b) were larger than
the residual system distortions alone (Figure 6.3.a).
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Table 6.2: Variations in the contour volumes and overlap comparisons between original and
distorted contour volumes. Phantom data consists of systematic distortions while patient
scans also include patient-specific distortions and setup uncertainties.
Scanner Contour
Mean undistorted
volume ± 2σ
(cm3)
Mean maximum
distortion ± 2σ (mm)
within contour
Mean DSC
± 2σ for each
contour
Skyra CTV (R) 796.0 ± 737.7 2.99 ± 1.18 0.972 ± 0.007
phantom (L) 485.8 ± 641.3 2.60 ± 0.75 0.966 ± 0.009
Seroma (R) 28.0 ± 87.2 1.03 ± 1.10 0.958 ± 0.081
(L) 11.0 ± 16.0 1.21 ± 0.39 0.914 ± 0.119
CB (R) 974.9 ± 774.6 3.73 ± 1.48 0.967 ± 0.006
(L) 585.0 ± 515.5 2.90 ± 0.61 0.969 ± 0.006
Combined Lung 2462 ± 1220 2.96 ± 1.34 0.981 ± 0.004
Heart 477.6 ± 134.4 1.37 ± 0.60 0.990 ± 0.006
Pamorama CTV (R) 2.87 ± 0.53 0.966 ± 0.011
phantom (L) 2.45 ± 1.37 0.952 ± 0.021
Seroma (R) 2.31 ± 0.45 0.964 ± 0.100
(L) 2.01 ± 0.42 0.904 ± 0.069
CB (R) 3.43 ± 1.18 0.957 ± 0.014
(L) 2.80 ± 0.49 0.959 ± 0.018
Combined Lung 4.87 ± 1.71 0.968 ± 0.007
Heart As above 2.01 ± 0.21 0.980 ± 0.009
Skyra CTV (R) 5.90 ± 4.64 0.942 ± 0.023
patient (L) 6.63 ± 6.90 0.914 ± 0.063
Seroma (R) 3.70 ± 3.97 0.818 ± 0.192
(L) 4.55 ± 4.20 0.744 ± 0.157
CB (R) 6.44 ± 3.10 0.942 ± 0.023
(L) 7.02 ± 4.38 0.914 ± 0.063
Combined Lung 11.33 ± 8.63 0.929 ± 0.038
Heart 9.12 ± 7.06 0.922 ± 0.054
Abbreviations: CB = Contralateral Breast; R = Right sided patient; L = Left sided patient; σ = standard
deviation; DSC = Dice similarity coefficient
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Figure 6.3: Coronal comparison of the CTV (green), contralateral breast (pink), lung (blue)
and heart (red) volumes relative to distortions ≥ 2 mm for a) the Skyra phantom, b) an
example Skyra patient dataset (incorporating patient and system related distortions as well
as set-up uncertainties) and c) the Panorama phantom. Scales set relative to maximum
distortion in b). Visualisation by http://smili-project.sourceforge.net/
6.3.3 Dosimetric impact
Mean variations in DVH criteria between distorted plans optimised on the distorted dataset
compared to that of the distorted plan recomputed on the original datasets are shown in table
6.3. All plans optimised on both the Skyra and Panorama phantom distorted datasets passed
both the DVH and visual assessment when recomputed on the original CT dataset. Of the 18
plans optimised on the CT datasets non-rigidly registered to the Skyra patient images, 4 right
sided and 4 left sided patients failed the clinical tolerances when recomputed on the original
dataset (2 failed DVH, 4 failed visual, 2 failed DVH and visual assessments). Three of the
eight patients imaged at the higher BW resulted in plans with large dosimetric variations
when recomputed on the original CT, rendering them clinically unacceptable. Figure 6.4
compares DVHs for two patient datasets for the combined Skyra distortions (with 1 passing
and one failing), Skyra systematic and Panorama systematic distortions. Both patient images
were acquired with a pixel BW of 450 Hz/pixel.
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Table 6.3: Quantitative assessment of the DVH parameters and the clinical plan acceptance.
All numbers were computed based on dose optimised on distorted datasets less dose when
recomputed on undistorted dataset.
Dose criteria
Mean difference
± 2 σ
(Skyra phantom)
Mean difference
± 2 σ
(Panorama phantom)
Mean difference
± 2 σ
(Skyra patient)
Right
PTV V47.5 Gy 0.17 ± 1.18 % 0.46 ± 1.77 % 0.32 ± 2.51 %
Max 1 cc -0.15 ± 0.25 Gy 0.00 ± 0.40 Gy 0.18 ± 0.70 Gy
Seroma V47.5 Gy 0.08 ± 0.81 % -0.09 ± 0.49 % 0.20 ± 1.72 Gy
Max 1 cc 0.05 ± 0.23 Gy 0.21 ± 0.35 Gy 0.13 ± 0.84 Gy
Ipsilateral lung V20 Gy -0.13 ± 0.38 % -0.48 ± 0.86 % 0.77 ± 2.72 %
Heart Mean 0.03 ± 0.27 Gy -0.02 ± 0.14 Gy -0.01 ± 0.28 Gy
CB Max 1 cc -0.03 ± 0.10 Gy -0.06 ± 0.30 Gy 0.10 ± 0.57 Gy
Left
PTV V47.5 Gy -0.82 ± 1.16 % 0.28 ± 1.43 % -0.73 ± 1.93 %
Max 1 cc -0.02 ± 0.08 Gy 0.03 ± 0.15 Gy 0.45 ± 0.99 Gy
Seroma V47.5 Gy -0.50 ± 1.56 % -0.47 ± 2.00 % -0.35 ± 1.68 %
Max 1 cc -0.18 ± 0.61 Gy -0.02 ± 0.23 Gy 0.20 ± 0.87 Gy
Ipsilateral lung V20 Gy -0.18 ± 0.53 % 0.25 ± 0.58 % -0.30 ± 1.81 %
Heart Mean 0.13 ± 1.34 Gy -0.08 ± 0.20 Gy -0.38 ± 0.85 Gy
CB Max 1 cc -0.03 ± 0.10 Gy -0.1 ± 0.20 Gy 0.33 ± 2.36 Gy
Combined lung V20 Gy -0.06 ± 0.23 % -0.14 ± 0.43 % -0.09 ± 0.68 %
Plan pass/fail Overall 18 3 / 0 7 18 3 / 0 7 10 3 / 8 7
Abbreviations: CB = Contralateral Breast; 3 plan met acceptance criteria, 7 plan did not meet acceptance
criteria
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Figure 6.4: DVHs for 2 patients showing the variation in dose coverage between the different
distortions assessed. 3 plan met acceptance criteria, 7 plan did not meet acceptance criteria.
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6.4 Discussion
The assessment of the dosimetric impact of geometric distortion in this study (Figure 6.1)
considers the following:
1. How are plans currently being generated? (Plan optimisation on correct CT geometry)
2. What would happen if we were to plan on MRI geometry? (Plan optimisation based
on incorrect geometry)
3. How does this translate into what is actually being treated? (Incorrect geometry opti-
misation recomputed on the correct geometry)
In distorting the CT datasets to match the MRI geometry as measured by both phantoms
and patients, it was possible to assess the distortion impact from system related distortions
and patient effects without the added question of the impact of the assignment of electron
density to various tissue types.
Systematic geometric distortions remaining after the application of vendor supplied cor-
rection algorithms differ between MRI scanners. Results have shown that residual system
distortions can vary greatly between two different scanners, both utilised for RTP simula-
tion. However, the effect of these distortions alone was found to have minimal impact on
photon dosimetry. Residual systematic distortions combined with patient related distortions
(including patient set-up) potentially have a larger impact on dosimetric variation, requiring
consideration if utilising patient geometry as observed on MRI in the radiotherapy planning
process.
Most modern scanners come with the option to apply geometric correction algorithms to
account for the gradient nonlinearities in 2D and/or 3D. Though distortions may not be
completely removed, a reduction in systematic distortions is visible when applying the 2D
correction over no correction [Chapter 3], and when applying the 3D correction over the
2D correction [Chapter 5]. Patient MRIs were acquired with a vendor supplied 2D correc-
tion algorithm as the 3D correction was unavailable at commencement of patient imaging.
Maximum distortions on the Skyra with the 3D correction algorithm applied are reduced
from 7.88 mm to 4.08 mm. However, images corrected using the 2D algorithm provide a
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"worst case" scenario and the dosimetric impact from application of the 3D correction can
be expected to be smaller.
Both the wide, closed bore 3.0 T Skyra and the vertical, open bore 1.0 T Panorama per-
formed similarly in terms of dosimetric impact when looking at the residual system dis-
tortions as determined by phantom measurements. Despite the known increase in gradient
nonlinearity distortions with increased distance from isocentre, residual distortions of lat-
erally positioned breasts did not adversely impact dosimetry. Maximum distortion values
observed within contoured regions for the Skyra patient distorted datasets were on aver-
age 3.8 times greater than those corresponding to the phantom data alone, indicating that
the patient-induced distortions (and associated set-up errors) were larger than that of the
residual system distortions.
Datasets incorporating both patient and system related distortions were found to have greater
dosimetric impact than the residual system distortions alone. On average, plans generated
on patient distorted images were more inhomogeneous with increased hot and cold regions
when recomputed on the original CT geometry. The probability of a distorted plan passing
or failing did not correlate with laterality, extent of contour distortion, patient size or pixel
bandwidth. Placing a patient within the magnetic field leads to geometric distortions arising
from chemical shift and susceptibility artefacts. These effects are the result of variations
in the magnetic properties of tissues within the body. This is an issue for breast imaging
where there are interfaces between glandular tissue, fatty tissue, muscle, ribs and lungs. The
chemical shift due to difference in water and fat signals is 440 Hz at 3 T (220 Hz at 1.5
T), resulting in field perturbations of 3.5 parts per million (ppm). Field perturbations due
to susceptibility between different tissues can be as large as 6 ppm [3]. Increasing the BW
further could have benefit in reducing the susceptibility effects, though this would come at
the expense of the SNR which may limit clinical utility.
These findings vary from investigations on the prostate and brain, where system and patient
distortions were not found to have a significant impact on dosimetry [73, 98, 99]. However,
these studies were conducted on scanners of lower field strengths. Additionally, these sites
generally have smaller air-tissue interface regions near the target. The combined distortion
effects were investigated on a 3.0 T magnet for this study, which has higher susceptibility
variations than lower strength systems [128]. Differences may also be due to the peripheral
location of the breast, resulting in less complicated treatment beams and organs requiring
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sparing.
While vendor supplied distortion corrections are essential to minimise the dosimetric impact
of system related distortions, our results suggest that patient correction methods may play
a role in reducing the dosimetric impact of geometric distortions on the planning process.
Techniques such as B0 mapping [122] or the acquisition of 2 images of reversed frequency
encode direction [65] that could reduce patient susceptibility effects will be investigated in
future work.
Due to the retrospective dataset utilised for this study, there was no way to separate the
errors due to the patient distortion and those from setup variations. As such, a number of
techniques were utilised to minimise the impact of any setup errors on this study. MRI
and CT images were acquired on the same day to reduce variations due to changing patient
anatomy over time. The patient CT and MRIs were rigidly registered prior to deformable
registration to reduce setup errors to within the tolerance values to minimise dosimetric
variations. Systematic and random setup errors for whole breast radiotherapy have been re-
ported as 1-2 mm and 2-3 mm respectively [129]. Harron et al. reported that for translational
shifts of 5 mm would result in a less than 5% variation in the target volume receiving 95%
and 107% of the prescribed dose [130]. DVH variations across all three datasets within our
study were less than these reported setup values. The hybrid IMRT technique utilised for
this study (80% dose through open beams, 20% dose through IMRT beams) has also been
found to the most be robust treatment technique when dealing with setup errors for whole
breast radiotherapy [129, 131].
The image registration presents another potential study limitation since the plans are being
generated on manipulated images and structures. The registration accuracy was within a
voxel size within the chest region of interest. When registering the patient CT and MRIs,
there were some differences around the patients’ arms due to slight positional variations.
Since these were well out of the dose calculation region, these variations were not consid-
ered. Image registration is also a point of consideration when utilising both CT and MRIs
in the planning process [92].
The automatic beam angles generated on the distorted datasets were the same between the
original plan and the Skyra residual distortion plans. The beam angle varied from the origi-
nal in 7 of the patient distorted plans and 4 of the Panorama distorted plans by 1-4o. Of the
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patient distorted plans with varied beam angles, only one resulted in a plan which was not
considered clinically acceptable once recomputed on the original, resulting in a hotter plan
with more lateral dose.
The isocentre of all beams corresponded to the centre of the PTV. Matching the beams
isocentre to the centre of the PTV represents a likely clinical scenario. While the presence
of distortion changes the location of the centre of PTV and consequently the beam isocentre
shifts relative to an undistorted geometry. If MRI-only planning was being utilised then
this represents what would happen between the planning and treatment stages due to the
variations in geometry.
Distortion mitigation must be addressed if moving towards MRI-only planning where a
patient CT would not be available for reference. Although our results showed the influence
of the scanners alone had minimal impact, it is important to quantify the geometric accuracy
of each system. This is especially important for future MRI-linac treatment units where
magnet and gradient specifications will be worse, as well as on higher field strength systems
where the patient effects may be more problematic.
These results are specific to whole breast IMRT treatments. While breast treatment volumes
extend into FOV regions where geometric distortions are largest, the dosimetric impact from
residual system distortions alone appear small. Since breast is a relatively homogeneous tis-
sue structure, the photon interactions may be more forgiving of these geometric variations.
In anatomical sites with multiple structures, the dosimetric impact of residual distortions
may be larger due to more complex planning methods and tissue variations. A similar in-
vestigation looking at partial breast radiotherapy would provide a good comparison to the
whole breast scenario. In a partial breast treatment, the dosimetric impact may be increased
with smaller treatment volumes and more targeted fields. Investigation into the combined ef-
fects of patient and systematic distortions require further investigation on the 1.0T Panorama
open-bore.
6.5 Conclusion
Combined MRI systematic and patient related distortions can result in unacceptable dosi-
metric variations for whole breast IMRT if considering MRI-only radiotherapy treatment
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planning. Residual system distortions alone had minimal impact on the dosimetry variations
for 2 different scanners of differing configurations and field strengths. Improved methods to
account for patient specific distortion may be beneficial to minimise dosimetric variations if
using MRI alone in the treatment planning process.
Chapter 7
Summary and future work
The use of MRI for radiotherapy treatment planning is increasing. MR images have superior
soft tissue contrast compared to CT and provide substantial benefits in radiotherapy: for
staging, tumour delineation, image guidance and treatment response. This thesis presents
a study into the geometric distortions on clinical MRI scanners to be used for RTP and the
implications for whole breast radiotherapy treatment planning.
7.1 Quantifying MRI geometric distortion utilising a 2D
phantom
Chapter 3 quantified the geometric distortions on four different diagnostic MRI scanners
using a diagnostic 2D QA phantom. The results showed varying geometric distortions on
each scanner, with the distortion increasing in magnitude further out from the isocentre of
the magnet. On each scanner, the distortion distribution varied slightly between spin echo
and gradient echo image acquisitions.
Research questions:
What are the variations in geometric distortion when scanning with and without
the application of a vendor supplied 2D correction algorithm?
The application of vendor supplied 2-dimensional correction algorithms reduces the
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magnitude of geometric distortions. While the maximum and mean distortion val-
ues were reduced, they were not completely removed. For a 3D turbo spin echo se-
quence, the maximum distortion observed beyond a radial distance of 100 mm from
the isocentre was reduced from 4.4 mm to 2.8 mm. However, the maximum distor-
tion was greater for the image with the correction algorithm applied within a 100 mm
radial distance (i.e. the correction algorithm provided no benefit within this region).
Similarly, the mean distortion within 100 mm from isocentre increased by 10% with
the correction algorithm applied.
The correction algorithms applied in this section only work to correct for distortions
in a 2D imaging plane. The third imaging plane, corresponding to the determination
of individual image slices were not corrected for.
What is the magnitude of geometric distortions corresponding to the location of
common radiotherapy anatomical sites within the scanner?
The largest distortions were observed in the peripheral regions within the scanner
where the lung and breast are likely to lie. Additionally, the patient contour should also
be considered in these regions too, which is important when considering the dosimetric
impact. In central axial slices of the scanner, systematic geometric distortions within
the brain stem, cervix, prostate and larynx are likely to be below 1 mm.
What are the limitations when using a 2 dimensional diagnostic imaging phan-
tom for measuring distortion for radiotherapy treatment planning purposes?
The phantom dimensions were a limiting factor in being able to quantify the MRI
distortions across a large field of view, as would be required for the purposes of RTP.
The size of the grid component within the studied phantom was only 277 mm x 277
mm x 25 mm, limiting the capability of the phantom to encompass a large FOV. The
2D grid pattern meant that distortions could only be quantified at one location at a
time and any phantom movement would be manual.
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7.2 Design & construction of a full field of view 3D MRI
distortion phantom
In Chapter 4, potential designs for a 3D MRI phantom for quantifying system related ge-
ometric distortions were investigated. A number of prototypes were developed and tested
before the final phantom was designed.
Research questions:
What specifications are required for a full field of view phantom for MRI distor-
tion assessment for radiotherapy planning?
The ideal specifications identified for a MRI distortion phantom, appropriate for de-
termining system related distortions for the purposes of radiotherapy were:
(i) An MRI compatible design
(ii) Grid points localised in all 3 imaging planes
(iii) Capable of quantifying geometric distortions across a large FOV
(iv) Practical design
(v) Visualisation of the 3D grid points both CT and MRI for the purpose of image analysis
and distortion quantification.
Is the designed phantom appropriate for measuring distortion for RTP?
The phantom developed in this study met the ideal phantom specifications. By design,
the materials utilised were all MRI compatible. The offset locations of the vitamin
E capsules between adjacent phantom layers provided an environment in which 3D
grid points could be readily defined. While the capsules are longer in length (19
mm) than they are in diameter (8 mm), they could still be localised in all 3 imaging
planes and this dimension ratio minimised the susceptibility artifacts from the capsules
7.3. Geometric distortions on a 3 T MRI-simulator 107
themselves. The overall phantom had a diameter of 500 mm, height of 350 mm and
a length of 513 mm, encompassing the entire imaging FOV on a 70 cm closed bore
scanner. This made it adequate for quantifying geometric distortions across the full
imaging FOV as required for RTP. While the phantom weighed approximately 60 kg,
a grid phantom of similar dimensions and filled with liquid encased in a perspex box
would have weighed at least 100 kg. The phantom layers and associated tray made
transportation between departments as well as scanners quite achievable and there
are no issues with phantom leakage (which is a potential issue for large, liquid filled
grid phantoms). The vitamin E capsules could be visualised on both CT and MRI
and hence comparison of capsule locations between the two modalities makes the
quantification of geometric distortions achievable.
7.3 Geometric distortions on a 3 T MRI-simulator
In Chapter 5, the distortions on a MRI scanner, dedicated to MRI-simulation for radiother-
apy were examined. Images were acquired with the 2D and 3D vendor-supplied correction
algorithms to compare the differences in distortion distribution between the two. Differ-
ences in geometric distortions between image acquisitions with a conventional static table
and a continuously moving table (TimCT) acquisitions were also measured.
Research questions:
What is the geometric performance of the MRI scanner with conventional ac-
quisition sequences?
On the Siemens 3T Skyra, the maximum distortion observed with a conventional ac-
quisition spin echo sequence over a FOV of 500 mm x 500 mm x 368 mm was 9.81
mm with a vendor supplied 2D correction algorithm applied during image acquisi-
tion. This was reduced to 4.37 mm when the 3D correction algorithm was applied.
The mean distortion across the whole volume was halved when comparing the 3D
corrected results to the 2D corrected results. This reduction in the magnitude of dis-
tortions observed is expected since the 3D correction algorithm corrects for gradient
non-linearities in the slice selection direction as well as the phase and frequency direc-
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tions. The 2D correction only corrects in the phase and frequency encoding directions.
Hence, 3D correction algorithms should be utilised (when available on the scanner).
This can be achieved during acquisition as well as retrospectively. With the 3D correc-
tion applied, distortions greater than 2 mm were not observed within a radial distance
of 150 mm from the isocentre of the scanner.
How do the distortion patterns obtained with a continuously moving couch com-
pare to static couch acquisitions?
The maximum distortions observed were reduced for the TimCT images when com-
pared to the conventional acquisition sequences. For a spoiled gradient echo sequence
with standard image acquisition (table speed = 0 mm/s), the maximum distortion ob-
served was 6.07 mm and only encompassed 71% of the phantom volume. For the
TimCT image acquisition with a table speed of 1.1 mm/s, the maximum distortion
reduced to 4.42 mm over the entire phantom volume, with the largest distortions ob-
served at the axial edges of the phantom. Whilst increasing the table speed by a
factor of 2 reduced the acquisition time, the magnitude of the distortions observed
increased and blurring was introduced as a result of the table movement, particularly
at the peripheral regions of the axial FOV. TimCT would be a useful imaging tech-
nique for anatomical sites which require large imaging lengths with a smaller axial
FOV (within a 200 mm radial distance from scanner isocentre). In cases where short
image lengths are required, the conventional static acquisition sequences may provide
the geometric accuracy required. The acquisition technique should be assessed on a
case by case basis. The increased geometric accuracy and coverage obtained when
imaging with TimCT needs to be traded-off for an increased scan time (by a factor of
3.5 for TimCT at 1.1 mm/s). Longer acquisition time could lead to increased patient
movement, resulting in artefacts in the images, reducing the usefulness of the images
for the purposes of RTP.
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7.4 Impact of geometric distortion on whole breast radio-
therapy
Chapter 6 investigated the implication of uncorrected geometric distortions on whole breast
radiotherapy treatment planning with intensity modulated radiotherapy in a retrospective
study over a patient cohort of 18. Phantom measurements quantified the residual systematic
distortions (after application of vendor supplied correction algorithms) on a wide, closed-
bore scanner (3 T Skyra) as well as a vertical open-bore scanner (1 T Panorama). The
distortion maps obtained from these measurements were used to quantify the impact of
systematic distortions alone. The phantom was not intended to be able to quantify patient
induced distortions. A comparison between patient CT and MR images enabled the effects
of combined systematic and patient induced distortions to be examined (Skyra only). The
maximum distortion on the Skyra was measured at 7.88 mm (mean = 2.07 mm; 95% of vol-
ume experienced distortions below 4.67 mm) over a 500 x 500 x 254 mm3 FOV. Maximum
distortion on the Panorama was measured at 11.87 mm (mean = 1.71 mm; 95% of volume
experienced distortions below 4.56 mm) over a 475 x 380 x 420 mm3 FOV.
Research questions:
How do systematic distortions on different MRI systems impact the dose distri-
bution for whole breast RTP?
Differences in geometric distortion were observed between the two scanners investi-
gated. The residual systematic distortions observed on each scanner (after application
of the vendor supplied correction algorithms on each system) were found to have neg-
ligible impact on dose distribution for tangential whole breast IMRT plans. All plans
generated on distorted CT data matching the systematic geometric distortions from
each MRI scanner met the DVH and visual acceptance criteria when recomputed on
the original CT image for both scanners. The mean difference in PTV V47.5 Gy was 0.17
± 1.18% and 0.32 ± 2.51% for the Skyra and Panorama scanners respectively. Com-
bined effects of the residual systematic and patient induced distortions were found
to have a more significant impact on dose with eight of the 18 patients investigated
having plans generated on the distorted image dataset fail the acceptable criteria when
recomputed on the correct CT geometry. Two datasets failed the DVH criteria, four
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patients were observed to fail the clinical visual plan criteria, and for two patients
plans failed both the DVH and visual assessments.
How do patient specific distortions impact whole breast radiotherapy?
By isolating and quantifying system distortions with a good phantom design, it was
possible to compare the relative magnitudes of systematic and patient related geomet-
ric distortions. The patient induced effects are larger than those introduced by the
system, particularly at higher field strengths. On the 3T skyra, the mean maximum
distortion observed over the CTV volumes from residual system distortions alone was
2.80 ± 0.97 mm. This increased to 6.25 ± 5.68 mm for the CTV volumes combining
residual systematic distortions, patient induced inaccuracies and set-up uncertainties.
This is due to the fact that the susceptibility variations are high in the breast with the
variations in tissue types (lung, muscles, bone and glandular tissue).
7.5 Future work
At the conclusion of the work covered in this thesis, there are a number of studies
which warrant further investigation. These include determining the impact of system-
atic and patient related distortions for other anatomical sites, quantifying MRI distor-
tions on scanners to be used for radiotherapy across Australia, better accounting for
patient induced distortions and to investigate the implications of geometric distortions
for MRI-linac systems.
7.5.1 Determining the impact of distortions for other anatomical sites
Investigations into the impact of systematic and patient induced distortions for other
clinical sites would be useful for the radiotherapy community. The methodology
utilised in Chapter 6 could be adapted for head and neck, cervix and lung. This would
give further indication into where the impact of these distortions is likely to be most
pronounced. The impact of distortion will depend on whether they can be addressed
on a relative or absolute scale. For breast the absolute distortions may be large com-
pared to the centre of the scanner, however in radiotherapy treatment planning, the
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treatment volume is set-up to the centre of the breast. Therefore the distortion mea-
surements are relative to the distortion experienced at the centre of the breast. For
other sites (e.g. lung), the treatment may be set up to a more central region in the
scanner and the absolute distortions would require consideration to determine how the
dose distribution is affected by a potentially distorted beam, compared to the geometry
at the centre of the image.
7.5.2 Survey of MRI distortions for RTP in radiation oncology depart-
ments across Australia
With the use of MRI increasing in radiation oncology, quantification of the geometric
distortions is crucial. As departments across Australia start utilising this modality
further, adequate methods for quantifying these distortions should be in place. The
3D phantom developed for this study could potentially be utilised to survey the MRI
scanners which may potentially be utilised in some capacity for imaging patients for
radiotherapy. This information would be beneficial to all departments in determining
the potential impact that the geometric distortions specific to their scanner may have
on their RTP procedures. Additionally, a correction method could be developed from
this work and applied where required to reduce larger geometric distortions.
7.5.3 Implications of geometric distortions on MRI-linac systems
Hybrid systems (such as the Australian MRI-linac) are designed to combine a linear
accelerator and magnetic field. Based on the physics of how each of these systems
work, both require modification in order to be able to function together in the same
room. Consequently, both the uniformity and linearity are significantly worse and
hence require careful assessment since this poses potential issues for planning and
image guidance throughout treatment. Methods for quantifying and correcting dis-
tortions will need to be in place in order for these systems to achieve the required
geometric performance.
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7.5.4 Accounting for patient-related distortions
Patient related distortions will play a significant part in accounting for MRI distor-
tions in the future. While correcting for these techniques was not discussed in this
work, correcting for these by B0 mapping [122] or reverse gradient image acquisition
[101] should be investigated further. Integrating these into the radiotherapy work-
flow would minimise the impact of patient related geometric distortions for radiother-
apy treatment planning. Ideally, a radiotherapy workflow should include methods for
quantifying both systematic and patient related distortions. Systematic quantification
would be less frequent, tested over time to ensure the consistency of the geometric
performance of the system. Quantification of patient distortions would require indi-
vidual assessment for situations where a high imaging bandwidth was undesirable or
unable to resolve the distortion problems.
7.6 Summary
This work has developed an MRI distortion phantom adequate for quantifying sys-
tematic distortions on clinical radiotherapy scanners with a number image acquisition
techniques, as well as determining the impact of patient and systematic distortions on
tangential whole breast IMRT plans. Vendor supplied correction algorithms should
always be utilised where possible in order to reduce the magnitude of systematic dis-
tortions to a more manageable level. Even with these corrections, geometric inaccu-
racies will still be present, with the largest distortions being found at the edges of the
imaging FOV. Combined patient and systematic effects can impact the dosimetry of
whole breast radiotherapy plans.
These advances in reducing geometric distortions, combined with widespread solu-
tions to generating electron density maps, will potentially lead to accurate MR-only
planning. While considered unlikely a few years ago, examples in the literature
[26, 132] suggest that we are on the threshold of MR-only planning for various treat-
ment sites. A truly exciting paradigm for radiotherapy treatment planning moving into
the future.
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